<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>MedicsKey | MedicsKey.A | Activity</title>
	<link>https://medicskey.com/members/cfb437c3/activity/</link>
	<atom:link href="https://medicskey.com/members/cfb437c3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for MedicsKey.A.</description>
	<lastBuildDate>Mon, 09 Mar 2026 08:53:57 +0800</lastBuildDate>
	<generator>https://buddypress.org/?v=2.16.1</generator>
	<language>zh-TW</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">6c9a7610e25a80df355e40fc84769647</guid>
				<title>MedicsKey.A started the discussion 兒童腦幹弥漫性膠質瘤的特徵性基因變異為H3.1或H3.3 K27M突變。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%85%92%e7%ab%a5%e8%85%a6%e5%b9%b9%e5%bc%a5%e6%bc%ab%e6%80%a7%e8%86%a0%e8%b3%aa%e7%98%a4%e7%9a%84%e7%89%b9%e5%be%b5%e6%80%a7%e5%9f%ba%e5%9b%a0%e8%ae%8a%e7%95%b0%e7%82%bah3-1%e6%88%96h3-3-k27m/</link>
				<pubDate>Mon, 13 Jan 2025 08:06:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%85%92%e7%ab%a5%e8%85%a6%e5%b9%b9%e5%bc%a5%e6%bc%ab%e6%80%a7%e8%86%a0%e8%b3%aa%e7%98%a4%e7%9a%84%e7%89%b9%e5%be%b5%e6%80%a7%e5%9f%ba%e5%9b%a0%e8%ae%8a%e7%95%b0%e7%82%bah3-1%e6%88%96h3-3-k27m/">兒童腦幹弥漫性膠質瘤的特徵性基因變異為H3.1或H3.3 K27M突變。</a></p> <div class="bb-content-inr-wrap"><p>11212-100 病理<br />
100.14歲男童於橋腦（pons）處有一經病理切片診斷為diffuse glioma, WHO grade II。針對brain stem glioma往往具有某特殊的基因變化，現已被歸屬成另外單獨類別之glioma，此特殊的基因變化是：<br />
A.ATRX loss<br />
B.H3.1 or H3.3 K27M mutation<br />
C.MGMT hypermethylation<br />
D.1p/19q co-deletion</p>
<p>正確答案: B.H3.1 or H3.3 K27M mutation</p>
<p>為何正確: 在腦幹膠質瘤（brain stem glioma），特別是彌漫性中線膠質瘤（diffuse midline&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-826"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%85%92%e7%ab%a5%e8%85%a6%e5%b9%b9%e5%bc%a5%e6%bc%ab%e6%80%a7%e8%86%a0%e8%b3%aa%e7%98%a4%e7%9a%84%e7%89%b9%e5%be%b5%e6%80%a7%e5%9f%ba%e5%9b%a0%e8%ae%8a%e7%95%b0%e7%82%bah3-1%e6%88%96h3-3-k27m/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">802039f7aab9f265a8f50d1301cd515a</guid>
				<title>MedicsKey.A started the discussion 庫賈氏症（Creutzfeldt-Jakob disease）患者大腦主要的病理變化是海綿狀腦病變（spongiform encephalopathy）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%ba%ab%e8%b3%88%e6%b0%8f%e7%97%87%ef%bc%88creutzfeldt-jakob-disease%ef%bc%89%e6%82%a3%e8%80%85%e5%a4%a7%e8%85%a6%e4%b8%bb%e8%a6%81%e7%9a%84%e7%97%85%e7%90%86%e8%ae%8a%e5%8c%96%e6%98%af%e6%b5%b7/</link>
				<pubDate>Mon, 13 Jan 2025 07:45:24 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%ba%ab%e8%b3%88%e6%b0%8f%e7%97%87%ef%bc%88creutzfeldt-jakob-disease%ef%bc%89%e6%82%a3%e8%80%85%e5%a4%a7%e8%85%a6%e4%b8%bb%e8%a6%81%e7%9a%84%e7%97%85%e7%90%86%e8%ae%8a%e5%8c%96%e6%98%af%e6%b5%b7/">庫賈氏症（Creutzfeldt-Jakob disease）患者大腦主要的病理變化是海綿狀腦病變（spongiform encephalopathy）。</a></p> <div class="bb-content-inr-wrap"><p>11212-99 病理<br />
99. 庫賈氏症（Creutzfeldt-Jakob disease）患者大腦主要的病理變化是：<br />
A.demyelinated plaque<br />
B.ring hemorrhage<br />
C.TH17 T cell infiltrate<br />
D.spongiform encephalopathy</p>
<p>正確答案: D.spongiform encephalopathy</p>
<p>為何正確: 庫賈氏症（Creutzfeldt-Jakob disease）是一種由傳染性海綿狀腦病所引起的中樞神經系統退行性疾病，其主要病理變化為海綿狀腦病變（spongiform&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-825"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%ba%ab%e8%b3%88%e6%b0%8f%e7%97%87%ef%bc%88creutzfeldt-jakob-disease%ef%bc%89%e6%82%a3%e8%80%85%e5%a4%a7%e8%85%a6%e4%b8%bb%e8%a6%81%e7%9a%84%e7%97%85%e7%90%86%e8%ae%8a%e5%8c%96%e6%98%af%e6%b5%b7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7764e39bd7a1ebcb66d987ece789fb18</guid>
				<title>MedicsKey.A started the discussion 圓形囊狀動脈瘤（saccular aneurysm），特別是位於Willis動脈環（circle of Willis）的動脈瘤，是非創傷性蜘蛛網膜下出血（subarachnoid hemorrhage）的最常見成因。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%93%e5%bd%a2%e5%9b%8a%e7%8b%80%e5%8b%95%e8%84%88%e7%98%a4%ef%bc%88saccular-aneurysm%ef%bc%89%ef%bc%8c%e7%89%b9%e5%88%a5%e6%98%af%e4%bd%8d%e6%96%bcwillis%e5%8b%95%e8%84%88%e7%92%b0%ef%bc%88circle/</link>
				<pubDate>Mon, 13 Jan 2025 07:42:24 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%93%e5%bd%a2%e5%9b%8a%e7%8b%80%e5%8b%95%e8%84%88%e7%98%a4%ef%bc%88saccular-aneurysm%ef%bc%89%ef%bc%8c%e7%89%b9%e5%88%a5%e6%98%af%e4%bd%8d%e6%96%bcwillis%e5%8b%95%e8%84%88%e7%92%b0%ef%bc%88circle/">圓形囊狀動脈瘤（saccular aneurysm），特別是位於Willis動脈環（circle of Willis）的動脈瘤，是非創傷性蜘蛛網膜下出血（subarachnoid hemorrhage）的最常見成因。</a></p> <div class="bb-content-inr-wrap"><p>11212-98 病理<br />
98.非創傷性蜘蛛網膜下出血（subarachnoid hemorrhage）最常見之成因是：<br />
A.arteriovenous malformation血管破裂<br />
B.cavernous hemangioma血管破裂<br />
C.arteriolar sclerosis血管破裂<br />
D.saccular aneurysm in the circle of Willis血管破裂</p>
<p>正確答案: D.saccular aneurysm in the circle of Willis 血管破裂</p>
<p>為何正確: 非創傷性蜘蛛網膜下出血（subarachnoid hemorrhage）最常見的成因是Willis氏環（circle of&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-824"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%93%e5%bd%a2%e5%9b%8a%e7%8b%80%e5%8b%95%e8%84%88%e7%98%a4%ef%bc%88saccular-aneurysm%ef%bc%89%ef%bc%8c%e7%89%b9%e5%88%a5%e6%98%af%e4%bd%8d%e6%96%bcwillis%e5%8b%95%e8%84%88%e7%92%b0%ef%bc%88circle/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">98e9bb622e6e3ee03aa4e7c6757750d1</guid>
				<title>MedicsKey.A started the discussion 高惡性度漿液性癌（high-grade serous carcinoma）屬於第二型（type II）卵巢上皮腫瘤。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e9%ab%98%e6%83%a1%e6%80%a7%e5%ba%a6%e6%bc%bf%e6%b6%b2%e6%80%a7%e7%99%8c%ef%bc%88high-grade-serous-carcinoma%ef%bc%89%e5%b1%ac%e6%96%bc%e7%ac%ac%e4%ba%8c%e5%9e%8b%ef%bc%88type-ii%ef%bc%89%e5%8d%b5/</link>
				<pubDate>Mon, 13 Jan 2025 07:34:49 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e9%ab%98%e6%83%a1%e6%80%a7%e5%ba%a6%e6%bc%bf%e6%b6%b2%e6%80%a7%e7%99%8c%ef%bc%88high-grade-serous-carcinoma%ef%bc%89%e5%b1%ac%e6%96%bc%e7%ac%ac%e4%ba%8c%e5%9e%8b%ef%bc%88type-ii%ef%bc%89%e5%8d%b5/">高惡性度漿液性癌（high-grade serous carcinoma）屬於第二型（type II）卵巢上皮腫瘤。</a></p> <div class="bb-content-inr-wrap"><p>11212-97 病理<br />
97.根據卵巢上皮癌的發生機轉，可區分為第一型（type I）與第二型（type II）腫瘤，下列何者為第二型（type II）腫瘤？<br />
A.子宮內膜樣癌（endometrioid carcinoma）<br />
B.亮細胞癌（clear cell carcinoma）<br />
C.低惡性度漿液性癌（low-grade serous carcinoma）<br />
D.高惡性度漿液性癌（high-grade serous carcinoma）</p>
<p>正確答案: D.高惡性度漿液性癌（high-grade serous carcinoma）</p>
<p>為何正確: 卵巢上皮癌可分為第一型（type I）和第二型（type&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-823"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e9%ab%98%e6%83%a1%e6%80%a7%e5%ba%a6%e6%bc%bf%e6%b6%b2%e6%80%a7%e7%99%8c%ef%bc%88high-grade-serous-carcinoma%ef%bc%89%e5%b1%ac%e6%96%bc%e7%ac%ac%e4%ba%8c%e5%9e%8b%ef%bc%88type-ii%ef%bc%89%e5%8d%b5/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4c2d2527334dd9619a0c80f5154fde77</guid>
				<title>MedicsKey.A started the discussion 卵巢漿液性癌（serous carcinoma）是最常見的卵巢上皮癌，雙側卵巢受累的比例通常高於20%。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%8d%b5%e5%b7%a2%e6%bc%bf%e6%b6%b2%e6%80%a7%e7%99%8c%ef%bc%88serous-carcinoma%ef%bc%89%e6%98%af%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e5%8d%b5%e5%b7%a2%e4%b8%8a%e7%9a%ae%e7%99%8c%ef%bc%8c%e9%9b%99/</link>
				<pubDate>Mon, 13 Jan 2025 07:11:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%8d%b5%e5%b7%a2%e6%bc%bf%e6%b6%b2%e6%80%a7%e7%99%8c%ef%bc%88serous-carcinoma%ef%bc%89%e6%98%af%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e5%8d%b5%e5%b7%a2%e4%b8%8a%e7%9a%ae%e7%99%8c%ef%bc%8c%e9%9b%99/">卵巢漿液性癌（serous carcinoma）是最常見的卵巢上皮癌，雙側卵巢受累的比例通常高於20%。</a></p> <div class="bb-content-inr-wrap"><p>11212-96 病理<br />
96.卵巢腫瘤中，最常見的是源自於穆勒氏上皮（Müllerian epithelium）的上皮性腫瘤，下列有關卵巢上皮性腫瘤<br />
的敘述， 何者最不適當？<br />
A.主要的組織型包括漿液性（serous）、黏液性（mucinous）與子宮內膜樣性（endometrioid）<br />
B.卵巢漿液性癌（serous carcinoma）為最常見的卵巢上皮癌，兩側卵巢皆被侵犯的比例很低 ，低於20%<br />
C.卵巢漿液性癌（serous carcinoma）可以分為高惡性度（high-grade）與低惡性度（low-grade）<br />
D.卵巢上皮癌中，第二常見組織型為子宮內膜樣癌（endometrioid carcinoma）</p>
<p>正確答案:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-822"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%8d%b5%e5%b7%a2%e6%bc%bf%e6%b6%b2%e6%80%a7%e7%99%8c%ef%bc%88serous-carcinoma%ef%bc%89%e6%98%af%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e5%8d%b5%e5%b7%a2%e4%b8%8a%e7%9a%ae%e7%99%8c%ef%bc%8c%e9%9b%99/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5c2dee4ad376ae3f3300e55e4fb988ae</guid>
				<title>MedicsKey.A started the discussion 大部分的低度鱗狀上皮內病灶與高危險性人類乳突狀病毒（high-risk human papillomavirus）的感染有關。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%a4%a7%e9%83%a8%e5%88%86%e7%9a%84%e4%bd%8e%e5%ba%a6%e9%b1%97%e7%8b%80%e4%b8%8a%e7%9a%ae%e5%85%a7%e7%97%85%e7%81%b6%e8%88%87%e9%ab%98%e5%8d%b1%e9%9a%aa%e6%80%a7%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81/</link>
				<pubDate>Sun, 12 Jan 2025 17:12:23 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%a4%a7%e9%83%a8%e5%88%86%e7%9a%84%e4%bd%8e%e5%ba%a6%e9%b1%97%e7%8b%80%e4%b8%8a%e7%9a%ae%e5%85%a7%e7%97%85%e7%81%b6%e8%88%87%e9%ab%98%e5%8d%b1%e9%9a%aa%e6%80%a7%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81/">大部分的低度鱗狀上皮內病灶與高危險性人類乳突狀病毒（high-risk human papillomavirus）的感染有關。</a></p> <div class="bb-content-inr-wrap"><p>11212-95 病理<br />
95.下列有關人類乳突狀病毒（human papillomavirus）與子宮頸癌或鱗狀前驅病灶（squamous cervical precursor lesions）的敘述，何者最不適當？<br />
A.大部分的鱗狀上皮內病灶（squamous intraepithelial lesion）不論是低度（low-grade）或高度（high-grade）都與人類乳突狀病毒的感染有關<br />
B.大部分的低度鱗狀上皮內病灶與低危險性人類乳突狀病毒（low-risk human&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-821"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%a4%a7%e9%83%a8%e5%88%86%e7%9a%84%e4%bd%8e%e5%ba%a6%e9%b1%97%e7%8b%80%e4%b8%8a%e7%9a%ae%e5%85%a7%e7%97%85%e7%81%b6%e8%88%87%e9%ab%98%e5%8d%b1%e9%9a%aa%e6%80%a7%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">03678c9487246ced7e2de9d5075b5de1</guid>
				<title>MedicsKey.A started the discussion 單發性副甲狀腺腺瘤（solitary parathyroid adenoma）是最常引起原發性副甲狀腺功能亢進症（primary hyperparathyroidism）的原因。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%96%ae%e7%99%bc%e6%80%a7%e5%89%af%e7%94%b2%e7%8b%80%e8%85%ba%e8%85%ba%e7%98%a4%ef%bc%88solitary-parathyroid-adenoma%ef%bc%89%e6%98%af%e6%9c%80%e5%b8%b8%e5%bc%95%e8%b5%b7%e5%8e%9f%e7%99%bc%e6%80%a7/</link>
				<pubDate>Sun, 12 Jan 2025 16:56:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%96%ae%e7%99%bc%e6%80%a7%e5%89%af%e7%94%b2%e7%8b%80%e8%85%ba%e8%85%ba%e7%98%a4%ef%bc%88solitary-parathyroid-adenoma%ef%bc%89%e6%98%af%e6%9c%80%e5%b8%b8%e5%bc%95%e8%b5%b7%e5%8e%9f%e7%99%bc%e6%80%a7/">單發性副甲狀腺腺瘤（solitary parathyroid adenoma）是最常引起原發性副甲狀腺功能亢進症（primary hyperparathyroidism）的原因。</a></p> <div class="bb-content-inr-wrap"><p>11212-94 病理<br />
94.最常造成原發性副甲狀腺功能亢進症（primary hyperparathyroidism）的原因是：<br />
A.primary hyperplasia<br />
B.parathyroid carcinoma<br />
C.multiple parathyroid adenomas<br />
D.solitary parathyroid adenoma</p>
<p>正確答案: D.solitary parathyroid adenoma</p>
<p>為何正確:<br />
原發性副甲狀腺功能亢進症（primary hyperparathyroidism）最常見的原因是單發性副甲狀腺腺瘤（solitary parathyroid&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-820"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%96%ae%e7%99%bc%e6%80%a7%e5%89%af%e7%94%b2%e7%8b%80%e8%85%ba%e8%85%ba%e7%98%a4%ef%bc%88solitary-parathyroid-adenoma%ef%bc%89%e6%98%af%e6%9c%80%e5%b8%b8%e5%bc%95%e8%b5%b7%e5%8e%9f%e7%99%bc%e6%80%a7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">947b52e2c8e62626f60be85cb9828c0a</guid>
				<title>MedicsKey.A started the discussion 腎臟微小病變（minimal-change disease）可能導致近曲小管上皮細胞中出現脂肪變性（lipid nephrosis）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%85%8e%e8%87%9f%e5%be%ae%e5%b0%8f%e7%97%85%e8%ae%8a%ef%bc%88minimal-change-disease%ef%bc%89%e5%8f%af%e8%83%bd%e5%b0%8e%e8%87%b4%e8%bf%91%e6%9b%b2%e5%b0%8f%e7%ae%a1%e4%b8%8a%e7%9a%ae%e7%b4%b0/</link>
				<pubDate>Sun, 12 Jan 2025 16:15:22 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%85%8e%e8%87%9f%e5%be%ae%e5%b0%8f%e7%97%85%e8%ae%8a%ef%bc%88minimal-change-disease%ef%bc%89%e5%8f%af%e8%83%bd%e5%b0%8e%e8%87%b4%e8%bf%91%e6%9b%b2%e5%b0%8f%e7%ae%a1%e4%b8%8a%e7%9a%ae%e7%b4%b0/">腎臟微小病變（minimal-change disease）可能導致近曲小管上皮細胞中出現脂肪變性（lipid nephrosis）。</a></p> <div class="bb-content-inr-wrap"><p>11212-93 病理<br />
93.有關腎臟微小病變（minimal-change disease）之特徵，下列敘述何者最適當？<br />
A.最主要的病理變化為腎小球中的壁上皮細胞（parietal epithelial cells）的足突消失<br />
B.腎小球的基底膜變厚<br />
C.近側腎小管上皮有脂質沉積<br />
D.在人類此疾病已證實與血管新生因子（angiopoietin-like&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-819"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%85%8e%e8%87%9f%e5%be%ae%e5%b0%8f%e7%97%85%e8%ae%8a%ef%bc%88minimal-change-disease%ef%bc%89%e5%8f%af%e8%83%bd%e5%b0%8e%e8%87%b4%e8%bf%91%e6%9b%b2%e5%b0%8f%e7%ae%a1%e4%b8%8a%e7%9a%ae%e7%b4%b0/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">f9bbfbeb311675a208958e2c53dd2c0d</guid>
				<title>MedicsKey.A started the discussion 嗜中性白血球（neutrophils）在硬化性後腹腔纖維化（sclerosing retroperitoneal fibrosis）的病灶中不常見。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%97%9c%e4%b8%ad%e6%80%a7%e7%99%bd%e8%a1%80%e7%90%83%ef%bc%88neutrophils%ef%bc%89%e5%9c%a8%e7%a1%ac%e5%8c%96%e6%80%a7%e5%be%8c%e8%85%b9%e8%85%94%e7%ba%96%e7%b6%ad%e5%8c%96%ef%bc%88sclerosing-retrope/</link>
				<pubDate>Sun, 12 Jan 2025 16:05:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%97%9c%e4%b8%ad%e6%80%a7%e7%99%bd%e8%a1%80%e7%90%83%ef%bc%88neutrophils%ef%bc%89%e5%9c%a8%e7%a1%ac%e5%8c%96%e6%80%a7%e5%be%8c%e8%85%b9%e8%85%94%e7%ba%96%e7%b6%ad%e5%8c%96%ef%bc%88sclerosing-retrope/">嗜中性白血球（neutrophils）在硬化性後腹腔纖維化（sclerosing retroperitoneal fibrosis）的病灶中不常見。</a></p> <div class="bb-content-inr-wrap"><p>11212-92 病理<br />
92.下列何種炎症細胞最不可能出現在硬化性後腹腔纖維化（sclerosing retroperitoneal fibrosis）的病灶中？<br />
A.淋巴球<br />
B.IgG4陽性漿細胞<br />
C.嗜酸性白血球<br />
D.嗜中性白血球</p>
<p>正確答案: D.嗜中性白血球</p>
<p>為何正確: 硬化性後腹腔纖維化（sclerosing retroperitoneal fibrosis）的病灶中通常會出現淋巴球（lymphocytes）、IgG4陽性漿細胞（IgG4-positive plasma cells）和嗜酸性白血球（eosinophils）。這些細胞參與慢性炎症反應，與IgG4相關疾病（IgG4-related&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-818"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%97%9c%e4%b8%ad%e6%80%a7%e7%99%bd%e8%a1%80%e7%90%83%ef%bc%88neutrophils%ef%bc%89%e5%9c%a8%e7%a1%ac%e5%8c%96%e6%80%a7%e5%be%8c%e8%85%b9%e8%85%94%e7%ba%96%e7%b6%ad%e5%8c%96%ef%bc%88sclerosing-retrope/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">090f0f15bf1863515ce9f02189adae6b</guid>
				<title>MedicsKey.A started the discussion 在威爾森氏病（Wilson disease）診斷中，血清的銅藍蛋白（ceruloplasmin）濃度和肝臟的銅離子濃度具高度診斷價值。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%a8%e5%a8%81%e7%88%be%e6%a3%ae%e6%b0%8f%e7%97%85%ef%bc%88wilson-disease%ef%bc%89%e8%a8%ba%e6%96%b7%e4%b8%ad%ef%bc%8c%e8%a1%80%e6%b8%85%e7%9a%84%e9%8a%85%e8%97%8d%e8%9b%8b%e7%99%bd%ef%bc%88cerulo/</link>
				<pubDate>Sun, 12 Jan 2025 16:01:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%a8%e5%a8%81%e7%88%be%e6%a3%ae%e6%b0%8f%e7%97%85%ef%bc%88wilson-disease%ef%bc%89%e8%a8%ba%e6%96%b7%e4%b8%ad%ef%bc%8c%e8%a1%80%e6%b8%85%e7%9a%84%e9%8a%85%e8%97%8d%e8%9b%8b%e7%99%bd%ef%bc%88cerulo/">在威爾森氏病（Wilson disease）診斷中，血清的銅藍蛋白（ceruloplasmin）濃度和肝臟的銅離子濃度具高度診斷價值。</a></p> <div class="bb-content-inr-wrap"><p>11212-91 病理<br />
91.有關肝臟的威爾森氏病（Wilson disease），下列何種生化檢查的診斷價值最低？<br />
A.血清的銅離子濃度<br />
B.血清的銅藍蛋白（ceruloplasmin）濃度<br />
C.肝臟的銅離子濃度<br />
D.尿液的銅離子濃度</p>
<p>正確答案: A.血清的銅離子濃度</p>
<p>為何正確: 威爾森氏病（Wilson&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-817"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%a8%e5%a8%81%e7%88%be%e6%a3%ae%e6%b0%8f%e7%97%85%ef%bc%88wilson-disease%ef%bc%89%e8%a8%ba%e6%96%b7%e4%b8%ad%ef%bc%8c%e8%a1%80%e6%b8%85%e7%9a%84%e9%8a%85%e8%97%8d%e8%9b%8b%e7%99%bd%ef%bc%88cerulo/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">46036a9b0340978f158d869399773869</guid>
				<title>MedicsKey.A started the discussion 口咽（oropharynx）的鱗狀細胞癌與人類乳突瘤病毒（human papillomavirus）高度相關。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%8f%a3%e5%92%bd%ef%bc%88oropharynx%ef%bc%89%e7%9a%84%e9%b1%97%e7%8b%80%e7%b4%b0%e8%83%9e%e7%99%8c%e8%88%87%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81%e7%98%a4%e7%97%85%e6%af%92%ef%bc%88human-papillomaviru/</link>
				<pubDate>Sun, 12 Jan 2025 15:58:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%8f%a3%e5%92%bd%ef%bc%88oropharynx%ef%bc%89%e7%9a%84%e9%b1%97%e7%8b%80%e7%b4%b0%e8%83%9e%e7%99%8c%e8%88%87%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81%e7%98%a4%e7%97%85%e6%af%92%ef%bc%88human-papillomaviru/">口咽（oropharynx）的鱗狀細胞癌與人類乳突瘤病毒（human papillomavirus）高度相關。</a></p> <div class="bb-content-inr-wrap"><p>11212-90 病理<br />
90.下列何處的鱗狀細胞癌（squamous cell carcinoma）與人類乳突瘤病毒（human papillomavirus）最為相關？<br />
A.牙齦（gingiva）<br />
B.頰黏膜（buccal mucosa）<br />
C.口咽（oropharynx）<br />
D.食道（esophagus）</p>
<p>正確答案: C.口咽（oropharynx）</p>
<p>為何正確: 口咽（oropharynx）的鱗狀細胞癌（squamous cell carcinoma）與人類乳突瘤病毒（human papillomavirus,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-816"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%8f%a3%e5%92%bd%ef%bc%88oropharynx%ef%bc%89%e7%9a%84%e9%b1%97%e7%8b%80%e7%b4%b0%e8%83%9e%e7%99%8c%e8%88%87%e4%ba%ba%e9%a1%9e%e4%b9%b3%e7%aa%81%e7%98%a4%e7%97%85%e6%af%92%ef%bc%88human-papillomaviru/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2b02e2bb896c61df6881fb34841dacbc</guid>
				<title>MedicsKey.A started the discussion 最常見的胰臟癌類型是胰腺癌（ductal carcinoma）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e8%83%b0%e8%87%9f%e7%99%8c%e9%a1%9e%e5%9e%8b%e6%98%af%e8%83%b0%e8%85%ba%e7%99%8c%ef%bc%88ductal-carcinoma%ef%bc%89%e3%80%82/</link>
				<pubDate>Sun, 12 Jan 2025 15:24:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e8%83%b0%e8%87%9f%e7%99%8c%e9%a1%9e%e5%9e%8b%e6%98%af%e8%83%b0%e8%85%ba%e7%99%8c%ef%bc%88ductal-carcinoma%ef%bc%89%e3%80%82/">最常見的胰臟癌類型是胰腺癌（ductal carcinoma）。</a></p> <div class="bb-content-inr-wrap"><p>11212-89 病理<br />
89.下列關於胰臟癌的敘述，何者最不適當？<br />
A.腺泡細胞癌（acinar cell carcinoma）是最常見的胰臟癌類型<br />
B.胰腺癌（ductal carcinoma）預後不良<br />
C.胰腺癌（ductal carcinoma）經常發現CDKN2A inactivation和KRAS突變<br />
D.大部分的胰腺癌（ductal carcinoma）發生在胰臟頭部（pancreatic head）</p>
<p>正確答案: A.腺泡細胞癌（acinar cell carcinoma）是最常見的胰臟癌類型</p>
<p>為何正確: 在胰臟癌中，最常見的類型是胰腺癌（ductal&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-815"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e8%83%b0%e8%87%9f%e7%99%8c%e9%a1%9e%e5%9e%8b%e6%98%af%e8%83%b0%e8%85%ba%e7%99%8c%ef%bc%88ductal-carcinoma%ef%bc%89%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4bf28fa0025ea48a50138c78879fca87</guid>
				<title>MedicsKey.A started the discussion 急性呼吸窘迫症候群（ARDS）與肺泡玻璃樣膜（hyaline membranes of alveoli）的形成最為相關。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e6%80%a5%e6%80%a7%e5%91%bc%e5%90%b8%e7%aa%98%e8%bf%ab%e7%97%87%e5%80%99%e7%be%a4%ef%bc%88ards%ef%bc%89%e8%88%87%e8%82%ba%e6%b3%a1%e7%8e%bb%e7%92%83%e6%a8%a3%e8%86%9c%ef%bc%88hyaline-membranes-of-alve/</link>
				<pubDate>Sun, 12 Jan 2025 15:19:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e6%80%a5%e6%80%a7%e5%91%bc%e5%90%b8%e7%aa%98%e8%bf%ab%e7%97%87%e5%80%99%e7%be%a4%ef%bc%88ards%ef%bc%89%e8%88%87%e8%82%ba%e6%b3%a1%e7%8e%bb%e7%92%83%e6%a8%a3%e8%86%9c%ef%bc%88hyaline-membranes-of-alve/">急性呼吸窘迫症候群（ARDS）與肺泡玻璃樣膜（hyaline membranes of alveoli）的形成最為相關。</a></p> <div class="bb-content-inr-wrap"><p>11212-88 病理<br />
88.肺泡玻璃樣膜（hyaline membranes of alveoli）與下列何種病變最為相關？<br />
A.慢性支氣管炎（chronic bronchitis）<br />
B.氣喘（asthma）<br />
C.急性呼吸窘迫症候群（ARDS）<br />
D.肺氣腫（emphysema）</p>
<p>正確答案: C.急性呼吸窘迫症候群（ARDS）</p>
<p>為何正確: 肺泡玻璃樣膜（hyaline membranes of alveoli）是急性呼吸窘迫症候群（ARDS）的典型病理特徵。ARDS會導致肺泡內壁上形成玻璃樣膜，這是由纖維蛋白滲出和壞死細胞的成分組成的。這種病理改變是對肺泡損傷的反應，也是ARDS診斷的重要依據。</p>
<p>選項: A.慢性支氣管炎（chronic bronchitis）<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-814"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e6%80%a5%e6%80%a7%e5%91%bc%e5%90%b8%e7%aa%98%e8%bf%ab%e7%97%87%e5%80%99%e7%be%a4%ef%bc%88ards%ef%bc%89%e8%88%87%e8%82%ba%e6%b3%a1%e7%8e%bb%e7%92%83%e6%a8%a3%e8%86%9c%ef%bc%88hyaline-membranes-of-alve/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">22282aff2cce07bd4711904a72e2c577</guid>
				<title>MedicsKey.A started the discussion α1-抗胰蛋白酶缺乏症（α1-antitrypsin deficiency）最常引起全腺泡型肺氣腫（panacinar emphysema）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%ce%b11-%e6%8a%97%e8%83%b0%e8%9b%8b%e7%99%bd%e9%85%b6%e7%bc%ba%e4%b9%8f%e7%97%87%ef%bc%88%ce%b11-antitrypsin-deficiency%ef%bc%89%e6%9c%80%e5%b8%b8%e5%bc%95%e8%b5%b7%e5%85%a8%e8%85%ba%e6%b3%a1%e5%9e%8b/</link>
				<pubDate>Sun, 12 Jan 2025 15:14:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%ce%b11-%e6%8a%97%e8%83%b0%e8%9b%8b%e7%99%bd%e9%85%b6%e7%bc%ba%e4%b9%8f%e7%97%87%ef%bc%88%ce%b11-antitrypsin-deficiency%ef%bc%89%e6%9c%80%e5%b8%b8%e5%bc%95%e8%b5%b7%e5%85%a8%e8%85%ba%e6%b3%a1%e5%9e%8b/">α1-抗胰蛋白酶缺乏症（α1-antitrypsin deficiency）最常引起全腺泡型肺氣腫（panacinar emphysema）。</a></p> <div class="bb-content-inr-wrap"><p>11212-87 病理<br />
87.α1-抗胰蛋白酶缺乏症（α1-antitrypsin deficiency）造成之肺氣腫類型多屬於下列何者？<br />
A.全腺泡型肺氣腫（panacinar emphysema）<br />
B.中心型肺氣腫（centriacinar emphysema）<br />
C.遠端腺泡型肺氣腫（distal acinar emphysema）<br />
D.不規則型肺氣腫（irregular emphysema）</p>
<p>正確答案: A.全腺泡型肺氣腫（panacinar emphysema）</p>
<p>為何正確: α1-抗胰蛋白酶缺乏症（α1-antitrypsin deficiency）是一種遺傳性疾病，此酶的缺乏會導致肺彈性組織的降解，進而造成全腺泡型肺氣腫（panacinar&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-813"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%ce%b11-%e6%8a%97%e8%83%b0%e8%9b%8b%e7%99%bd%e9%85%b6%e7%bc%ba%e4%b9%8f%e7%97%87%ef%bc%88%ce%b11-antitrypsin-deficiency%ef%bc%89%e6%9c%80%e5%b8%b8%e5%bc%95%e8%b5%b7%e5%85%a8%e8%85%ba%e6%b3%a1%e5%9e%8b/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7c027c866e332cd975a298efab489d7c</guid>
				<title>MedicsKey.A started the discussion 肺的鱗狀細胞癌（squamous cell carcinoma）最常出現高鈣血症（hypercalcemia）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%ba%e7%9a%84%e9%b1%97%e7%8b%80%e7%b4%b0%e8%83%9e%e7%99%8c%ef%bc%88squamous-cell-carcinoma%ef%bc%89%e6%9c%80%e5%b8%b8%e5%87%ba%e7%8f%be%e9%ab%98%e9%88%a3%e8%a1%80%e7%97%87%ef%bc%88hypercalcemia/</link>
				<pubDate>Sun, 12 Jan 2025 15:08:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%ba%e7%9a%84%e9%b1%97%e7%8b%80%e7%b4%b0%e8%83%9e%e7%99%8c%ef%bc%88squamous-cell-carcinoma%ef%bc%89%e6%9c%80%e5%b8%b8%e5%87%ba%e7%8f%be%e9%ab%98%e9%88%a3%e8%a1%80%e7%97%87%ef%bc%88hypercalcemia/">肺的鱗狀細胞癌（squamous cell carcinoma）最常出現高鈣血症（hypercalcemia）。</a></p> <div class="bb-content-inr-wrap"><p>11212-86 病理<br />
86.有關肺的鱗狀細胞癌（squamous cell carcinoma）的敘述，下列何者最適當？<br />
A.女性比男性多<br />
B.通常發生於肺部周邊區域<br />
C.EGFR有高度表現且常合併突變<br />
D.相對於其它組織形態，最常出現高鈣血症</p>
<p>正確答案: D.相對於其它組織形態，最常出現高鈣血症</p>
<p>為何正確: 肺的鱗狀細胞癌（squamous cell&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-812"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%ba%e7%9a%84%e9%b1%97%e7%8b%80%e7%b4%b0%e8%83%9e%e7%99%8c%ef%bc%88squamous-cell-carcinoma%ef%bc%89%e6%9c%80%e5%b8%b8%e5%87%ba%e7%8f%be%e9%ab%98%e9%88%a3%e8%a1%80%e7%97%87%ef%bc%88hypercalcemia/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">f6d35e1a273d86180a8dd9a667458526</guid>
				<title>MedicsKey.A started the discussion 再生障礙性貧血（aplastic anemia）最常見的病因是原發性（idiopathic），並不常伴隨脾臟腫大。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%86%8d%e7%94%9f%e9%9a%9c%e7%a4%99%e6%80%a7%e8%b2%a7%e8%a1%80%ef%bc%88aplastic-anemia%ef%bc%89%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e7%97%85%e5%9b%a0%e6%98%af%e5%8e%9f%e7%99%bc%e6%80%a7%ef%bc%88idiop/</link>
				<pubDate>Sun, 12 Jan 2025 15:01:29 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%86%8d%e7%94%9f%e9%9a%9c%e7%a4%99%e6%80%a7%e8%b2%a7%e8%a1%80%ef%bc%88aplastic-anemia%ef%bc%89%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e7%97%85%e5%9b%a0%e6%98%af%e5%8e%9f%e7%99%bc%e6%80%a7%ef%bc%88idiop/">再生障礙性貧血（aplastic anemia）最常見的病因是原發性（idiopathic），並不常伴隨脾臟腫大。</a></p> <div class="bb-content-inr-wrap"><p>11212-85 病理<br />
85.6歲男童兩週來出現面色蒼白、精神不佳。病童血液中紅血球、血小板、白血球數目減少。男童之前曾有類似感冒症狀，也服用過抗生素與退燒藥。骨髓切片檢查發現骨髓中約80%～90%都是脂肪組織，造血母細胞（blast&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-811"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%86%8d%e7%94%9f%e9%9a%9c%e7%a4%99%e6%80%a7%e8%b2%a7%e8%a1%80%ef%bc%88aplastic-anemia%ef%bc%89%e6%9c%80%e5%b8%b8%e8%a6%8b%e7%9a%84%e7%97%85%e5%9b%a0%e6%98%af%e5%8e%9f%e7%99%bc%e6%80%a7%ef%bc%88idiop/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">9b54e8c462560180fb66d31fd0cfd1c3</guid>
				<title>MedicsKey.A started the discussion Epstein-Barr病毒（Epstein-Barr virus）與鼻型NK/T細胞淋巴瘤相關，腫瘤細胞常表現CD56，且可見血管侵犯和組織壞死。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/epstein-barr%e7%97%85%e6%af%92%ef%bc%88epstein-barr-virus%ef%bc%89%e8%88%87%e9%bc%bb%e5%9e%8bnk-t%e7%b4%b0%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9b%b8%e9%97%9c%ef%bc%8c%e8%85%ab%e7%98%a4%e7%b4%b0/</link>
				<pubDate>Sun, 12 Jan 2025 14:53:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/epstein-barr%e7%97%85%e6%af%92%ef%bc%88epstein-barr-virus%ef%bc%89%e8%88%87%e9%bc%bb%e5%9e%8bnk-t%e7%b4%b0%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9b%b8%e9%97%9c%ef%bc%8c%e8%85%ab%e7%98%a4%e7%b4%b0/">Epstein-Barr病毒（Epstein-Barr virus）與鼻型NK/T細胞淋巴瘤相關，腫瘤細胞常表現CD56，且可見血管侵犯和組織壞死。</a></p> <div class="bb-content-inr-wrap"><p>11212-84 病理<br />
84.45歲女性，鼻腔腫瘤切片發現中等大小異常淋巴球浸潤，且有明顯的血管侵犯（angioinvasion）及組織壞死，免疫染色顯示腫瘤細胞表現CD56，此腫瘤最可能與何種病毒有關？<br />
A.人類嗜T淋巴球病毒第一型（human T-lymphotropic virus 1）<br />
B.Epstein-Barr病毒（Epstein-Barr virus）<br />
C.人類免疫缺乏病毒（human immunodeficiency virus）<br />
D.人類疱疹病毒第八型（human herpesvirus 8）</p>
<p>正確答案: B.Epstein-Barr病毒（Epstein-Barr virus）</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-810"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/epstein-barr%e7%97%85%e6%af%92%ef%bc%88epstein-barr-virus%ef%bc%89%e8%88%87%e9%bc%bb%e5%9e%8bnk-t%e7%b4%b0%e8%83%9e%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9b%b8%e9%97%9c%ef%bc%8c%e8%85%ab%e7%98%a4%e7%b4%b0/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">bf6377136a395f9faa53e833d985e2b0</guid>
				<title>MedicsKey.A started the discussion Transthyretin amyloidosis（運甲狀腺素蛋白相關澱粉樣變性）常見於老年人，沉積的澱粉樣蛋白呈無分支細絲狀結構，直徑約10～12微米。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/transthyretin-amyloidosis%ef%bc%88%e9%81%8b%e7%94%b2%e7%8b%80%e8%85%ba%e7%b4%a0%e8%9b%8b%e7%99%bd%e7%9b%b8%e9%97%9c%e6%be%b1%e7%b2%89%e6%a8%a3%e8%ae%8a%e6%80%a7%ef%bc%89%e5%b8%b8%e8%a6%8b%e6%96%bc/</link>
				<pubDate>Sun, 12 Jan 2025 14:49:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/transthyretin-amyloidosis%ef%bc%88%e9%81%8b%e7%94%b2%e7%8b%80%e8%85%ba%e7%b4%a0%e8%9b%8b%e7%99%bd%e7%9b%b8%e9%97%9c%e6%be%b1%e7%b2%89%e6%a8%a3%e8%ae%8a%e6%80%a7%ef%bc%89%e5%b8%b8%e8%a6%8b%e6%96%bc/">Transthyretin amyloidosis（運甲狀腺素蛋白相關澱粉樣變性）常見於老年人，沉積的澱粉樣蛋白呈無分支細絲狀結構，直徑約10～12微米。</a></p> <div class="bb-content-inr-wrap"><p>11212-83 病理<br />
83.72歲男性呈現心臟衰竭，右心壁肥厚及左心肥大，心肌切片檢查顯示在心肌間質有細絲狀物質沉積，此絲狀物直徑約10～12微米並呈無分支狀結構。下列何者最符合上述的病理變化？<br />
A.endocardial fibroelastosis<br />
B.ischemic interstitial fibrosis<br />
C.transthyretin amyloidosis<br />
D.postirradiation fibrosis</p>
<p>正確答案: C.transthyretin amyloidosis</p>
<p>為何正確: transthyretin&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-809"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/transthyretin-amyloidosis%ef%bc%88%e9%81%8b%e7%94%b2%e7%8b%80%e8%85%ba%e7%b4%a0%e8%9b%8b%e7%99%bd%e7%9b%b8%e9%97%9c%e6%be%b1%e7%b2%89%e6%a8%a3%e8%ae%8a%e6%80%a7%ef%bc%89%e5%b8%b8%e8%a6%8b%e6%96%bc/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7c60da1ae998765cfa11c584224db82e</guid>
				<title>MedicsKey.A started the discussion Von Willebrand病（Von Willebrand disease）是一種遺傳性出血性疾病，不會增加血栓的風險。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/von-willebrand%e7%97%85%ef%bc%88von-willebrand-disease%ef%bc%89%e6%98%af%e4%b8%80%e7%a8%ae%e9%81%ba%e5%82%b3%e6%80%a7%e5%87%ba%e8%a1%80%e6%80%a7%e7%96%be%e7%97%85%ef%bc%8c%e4%b8%8d%e6%9c%83%e5%a2%9e/</link>
				<pubDate>Sun, 12 Jan 2025 14:35:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/von-willebrand%e7%97%85%ef%bc%88von-willebrand-disease%ef%bc%89%e6%98%af%e4%b8%80%e7%a8%ae%e9%81%ba%e5%82%b3%e6%80%a7%e5%87%ba%e8%a1%80%e6%80%a7%e7%96%be%e7%97%85%ef%bc%8c%e4%b8%8d%e6%9c%83%e5%a2%9e/">Von Willebrand病（Von Willebrand disease）是一種遺傳性出血性疾病，不會增加血栓的風險。</a></p> <div class="bb-content-inr-wrap"><p>11212-82 病理<br />
82.下列疾病容易引起血栓（thrombosis），但何者除外？<br />
A.肝素引起血小板低下（heparin-induced thrombocytopenia）<br />
B.抗磷脂質抗體症候群（antiphospholipid antibody syndrome）<br />
C.Protein S缺乏（protein S deficiency）<br />
D.Von Willebrand disease</p>
<p>正確答案: D. Von Willebrand disease</p>
<p>為何正確: Von Willebrand病是一種因缺乏或功能異常的Von&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-808"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/von-willebrand%e7%97%85%ef%bc%88von-willebrand-disease%ef%bc%89%e6%98%af%e4%b8%80%e7%a8%ae%e9%81%ba%e5%82%b3%e6%80%a7%e5%87%ba%e8%a1%80%e6%80%a7%e7%96%be%e7%97%85%ef%bc%8c%e4%b8%8d%e6%9c%83%e5%a2%9e/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3b2b42ea4c73ac5a7b2e30bc08e06572</guid>
				<title>MedicsKey.A started the discussion 細菌性腹膜炎（peritonitis）引起的腹水含有最高的蛋白質濃度。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e7%b4%b0%e8%8f%8c%e6%80%a7%e8%85%b9%e8%86%9c%e7%82%8e%ef%bc%88peritonitis%ef%bc%89%e5%bc%95%e8%b5%b7%e7%9a%84%e8%85%b9%e6%b0%b4%e5%90%ab%e6%9c%89%e6%9c%80%e9%ab%98%e7%9a%84%e8%9b%8b%e7%99%bd%e8%b3%aa/</link>
				<pubDate>Sun, 12 Jan 2025 14:24:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e7%b4%b0%e8%8f%8c%e6%80%a7%e8%85%b9%e8%86%9c%e7%82%8e%ef%bc%88peritonitis%ef%bc%89%e5%bc%95%e8%b5%b7%e7%9a%84%e8%85%b9%e6%b0%b4%e5%90%ab%e6%9c%89%e6%9c%80%e9%ab%98%e7%9a%84%e8%9b%8b%e7%99%bd%e8%b3%aa/">細菌性腹膜炎（peritonitis）引起的腹水含有最高的蛋白質濃度。</a></p> <div class="bb-content-inr-wrap"><p>11212-81 病理<br />
81.下列造成腹水（ascites）的原因中，何種原因的積液所含的蛋白質濃度最高？<br />
A.細菌性腹膜炎（peritonitis）<br />
B.腎病症候群（nephrotic syndrome）<br />
C.肝硬化（liver cirrhosis）<br />
D.營養不良（malnutrition）</p>
<p>正確答案:<br />
A.細菌性腹膜炎（peritonitis）</p>
<p>為何正確:<br />
細菌性腹膜炎（peritonitis）所造成的腹水因為存在炎症過程，導致毛細血管通透性增加，蛋白質滲漏進入腹腔，因此其積液中蛋白質的濃度通常會比較高。</p>
<p>選項: A.細菌性腹膜炎（peritonitis）<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-807"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e7%b4%b0%e8%8f%8c%e6%80%a7%e8%85%b9%e8%86%9c%e7%82%8e%ef%bc%88peritonitis%ef%bc%89%e5%bc%95%e8%b5%b7%e7%9a%84%e8%85%b9%e6%b0%b4%e5%90%ab%e6%9c%89%e6%9c%80%e9%ab%98%e7%9a%84%e8%9b%8b%e7%99%bd%e8%b3%aa/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b417cab65d0ec0f031ec1859582741f8</guid>
				<title>MedicsKey.A started the discussion 當胃的原發性黏膜相關淋巴瘤（MALToma）發生轉移時，最常見的染色體變化是t(11;18)。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e7%95%b6%e8%83%83%e7%9a%84%e5%8e%9f%e7%99%bc%e6%80%a7%e9%bb%8f%e8%86%9c%e7%9b%b8%e9%97%9c%e6%b7%8b%e5%b7%b4%e7%98%a4%ef%bc%88maltoma%ef%bc%89%e7%99%bc%e7%94%9f%e8%bd%89%e7%a7%bb%e6%99%82%ef%bc%8c/</link>
				<pubDate>Sat, 11 Jan 2025 08:54:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e7%95%b6%e8%83%83%e7%9a%84%e5%8e%9f%e7%99%bc%e6%80%a7%e9%bb%8f%e8%86%9c%e7%9b%b8%e9%97%9c%e6%b7%8b%e5%b7%b4%e7%98%a4%ef%bc%88maltoma%ef%bc%89%e7%99%bc%e7%94%9f%e8%bd%89%e7%a7%bb%e6%99%82%ef%bc%8c/">當胃的原發性黏膜相關淋巴瘤（MALToma）發生轉移時，最常見的染色體變化是t(11;18)。</a></p> <div class="bb-content-inr-wrap"><p>11212-80 病理<br />
80.下列關於胃的原發性黏膜相關淋巴瘤（mucosa-associated lymphoid tissue lymphoma, MALToma）之敘述，何者最不適當？<br />
A.屬於B-cell lymphoma<br />
B.與其關係最密切之微生物為Helicobacter pylori<br />
C.cytotoxin-associated gene A（CagA）為其相關微生物之重要致病基因<br />
D.當其發生轉移時，最常出現之染色體變化為t(11;14)</p>
<p>正確答案:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-806"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e7%95%b6%e8%83%83%e7%9a%84%e5%8e%9f%e7%99%bc%e6%80%a7%e9%bb%8f%e8%86%9c%e7%9b%b8%e9%97%9c%e6%b7%8b%e5%b7%b4%e7%98%a4%ef%bc%88maltoma%ef%bc%89%e7%99%bc%e7%94%9f%e8%bd%89%e7%a7%bb%e6%99%82%ef%bc%8c/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2092d1122cf0d5b98f128cc16aff15ab</guid>
				<title>MedicsKey.A started the discussion 全身過敏性反應（systemic anaphylaxis）的臨床症狀一般與被活化的肥大細胞（mast cells）釋放引起血管活化的調節物質有關。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%85%a8%e8%ba%ab%e9%81%8e%e6%95%8f%e6%80%a7%e5%8f%8d%e6%87%89%ef%bc%88systemic-anaphylaxis%ef%bc%89%e7%9a%84%e8%87%a8%e5%ba%8a%e7%97%87%e7%8b%80%e4%b8%80%e8%88%ac%e8%88%87%e8%a2%ab%e6%b4%bb%e5%8c%96/</link>
				<pubDate>Sat, 11 Jan 2025 08:33:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%85%a8%e8%ba%ab%e9%81%8e%e6%95%8f%e6%80%a7%e5%8f%8d%e6%87%89%ef%bc%88systemic-anaphylaxis%ef%bc%89%e7%9a%84%e8%87%a8%e5%ba%8a%e7%97%87%e7%8b%80%e4%b8%80%e8%88%ac%e8%88%87%e8%a2%ab%e6%b4%bb%e5%8c%96/">全身過敏性反應（systemic anaphylaxis）的臨床症狀一般與被活化的肥大細胞（mast cells）釋放引起血管活化的調節物質有關。</a></p> <div class="bb-content-inr-wrap"><p>11212-79 病理<br />
79.關於過敏性疾病的敘述，下列何者最適當？<br />
A.鼻瘜肉（nasal polyp）一般被認為與IgE媒介所引發的外因性過敏性鼻炎或鼻竇炎（atopic allergic rhinitis or sinusitis）有關<br />
B.運動引發的過敏一般被認為主要是與TH2細胞的過度反應有關<br />
C.發炎性腸道疾病（inflammatory bowel disease）一般被認為主要與TH2細胞的過度反應有關<br />
D.全身過敏性反應（systemic anaphylaxis）的臨床症狀一般被認為與被活化的肥大細胞（mast cells）釋放一些引起血管活化調節物質有關</p>
<p>正確答案: D.全身過敏性反應（systemic&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-805"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%85%a8%e8%ba%ab%e9%81%8e%e6%95%8f%e6%80%a7%e5%8f%8d%e6%87%89%ef%bc%88systemic-anaphylaxis%ef%bc%89%e7%9a%84%e8%87%a8%e5%ba%8a%e7%97%87%e7%8b%80%e4%b8%80%e8%88%ac%e8%88%87%e8%a2%ab%e6%b4%bb%e5%8c%96/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a1a2299de3a1d46452788d0e2090051e</guid>
				<title>MedicsKey.A started the discussion 螢光原位雜交法（fluorescence in situ hybridization, FISH）可以診斷唐氏症（Down syndrome）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%9e%a2%e5%85%89%e5%8e%9f%e4%bd%8d%e9%9b%9c%e4%ba%a4%e6%b3%95%ef%bc%88fluorescence-in-situ-hybridization-fish%ef%bc%89%e5%8f%af%e4%bb%a5%e8%a8%ba%e6%96%b7%e5%94%90%e6%b0%8f%e7%97%87%ef%bc%88down-sy/</link>
				<pubDate>Sat, 11 Jan 2025 08:19:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%9e%a2%e5%85%89%e5%8e%9f%e4%bd%8d%e9%9b%9c%e4%ba%a4%e6%b3%95%ef%bc%88fluorescence-in-situ-hybridization-fish%ef%bc%89%e5%8f%af%e4%bb%a5%e8%a8%ba%e6%96%b7%e5%94%90%e6%b0%8f%e7%97%87%ef%bc%88down-sy/">螢光原位雜交法（fluorescence in situ hybridization, FISH）可以診斷唐氏症（Down syndrome）。</a></p> <div class="bb-content-inr-wrap"><p>11212-78 病理<br />
78.關於唐氏症候群（Down syndrome）的敘述，下列何者最適當？<br />
A.單核苷酸多態性（single nucleotide&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-804"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%9e%a2%e5%85%89%e5%8e%9f%e4%bd%8d%e9%9b%9c%e4%ba%a4%e6%b3%95%ef%bc%88fluorescence-in-situ-hybridization-fish%ef%bc%89%e5%8f%af%e4%bb%a5%e8%a8%ba%e6%96%b7%e5%94%90%e6%b0%8f%e7%97%87%ef%bc%88down-sy/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d5a7511f6b623003f094740fdc2c77d2</guid>
				<title>MedicsKey.A started the discussion 肝臟(肝臟)的再生能力是所有器官中最強的。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%9d%e8%87%9f%e8%82%9d%e8%87%9f%e7%9a%84%e5%86%8d%e7%94%9f%e8%83%bd%e5%8a%9b%e6%98%af%e6%89%80%e6%9c%89%e5%99%a8%e5%ae%98%e4%b8%ad%e6%9c%80%e5%bc%b7%e7%9a%84%e3%80%82/</link>
				<pubDate>Sat, 11 Jan 2025 08:16:22 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%9d%e8%87%9f%e8%82%9d%e8%87%9f%e7%9a%84%e5%86%8d%e7%94%9f%e8%83%bd%e5%8a%9b%e6%98%af%e6%89%80%e6%9c%89%e5%99%a8%e5%ae%98%e4%b8%ad%e6%9c%80%e5%bc%b7%e7%9a%84%e3%80%82/">肝臟(肝臟)的再生能力是所有器官中最強的。</a></p> <div class="bb-content-inr-wrap"><p>11212-77 病理<br />
77.下列何項器官或組織的再生能力最強？<br />
A.肺<br />
B.肌肉<br />
C.胰<br />
D.肝</p>
<p>正確答案: D.肝</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-803"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%9d%e8%87%9f%e8%82%9d%e8%87%9f%e7%9a%84%e5%86%8d%e7%94%9f%e8%83%bd%e5%8a%9b%e6%98%af%e6%89%80%e6%9c%89%e5%99%a8%e5%ae%98%e4%b8%ad%e6%9c%80%e5%bc%b7%e7%9a%84%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0c2da605d515a6002e00bee65bf4c8bf</guid>
				<title>MedicsKey.A started the discussion 傷口有過多膠原蛋白（collagen）堆積，生長超出原始傷口的邊界並不消退，稱為蟹足腫（keloid）。 in the forum 病理學</title>
				<link>https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%82%b7%e5%8f%a3%e6%9c%89%e9%81%8e%e5%a4%9a%e8%86%a0%e5%8e%9f%e8%9b%8b%e7%99%bd%ef%bc%88collagen%ef%bc%89%e5%a0%86%e7%a9%8d%ef%bc%8c%e7%94%9f%e9%95%b7%e8%b6%85%e5%87%ba%e5%8e%9f%e5%a7%8b%e5%82%b7/</link>
				<pubDate>Sat, 11 Jan 2025 07:44:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%82%b7%e5%8f%a3%e6%9c%89%e9%81%8e%e5%a4%9a%e8%86%a0%e5%8e%9f%e8%9b%8b%e7%99%bd%ef%bc%88collagen%ef%bc%89%e5%a0%86%e7%a9%8d%ef%bc%8c%e7%94%9f%e9%95%b7%e8%b6%85%e5%87%ba%e5%8e%9f%e5%a7%8b%e5%82%b7/">傷口有過多膠原蛋白（collagen）堆積，生長超出原始傷口的邊界並不消退，稱為蟹足腫（keloid）。</a></p> <div class="bb-content-inr-wrap"><p>11212-76 病理<br />
76.傷口有過多膠原蛋白（collagen）堆積，生長超出原始傷口的邊界，並且不消退，稱為：<br />
A.蟹足腫（keloid）<br />
B.肥厚疤（hypertrophic scar）<br />
C.肉芽腫（granuloma）<br />
D.肉芽組織（granulation tissue）</p>
<p>正確答案: A.蟹足腫（keloid）</p>
<p>為何正確: 蟹足腫（keloid）是指傷口修復過程中，膠原蛋白（collagen）過度堆積，導致疤痕組織生長超出原始傷口邊界，形成隆起且堅硬的結構，並且不會隨時間自行消退。相比之下，肥厚疤（hypertrophic&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-802"><a href="https://medicskey.com/groups/%e7%97%85%e7%90%86%e5%ad%b8/forum/discussion/%e5%82%b7%e5%8f%a3%e6%9c%89%e9%81%8e%e5%a4%9a%e8%86%a0%e5%8e%9f%e8%9b%8b%e7%99%bd%ef%bc%88collagen%ef%bc%89%e5%a0%86%e7%a9%8d%ef%bc%8c%e7%94%9f%e9%95%b7%e8%b6%85%e5%87%ba%e5%8e%9f%e5%a7%8b%e5%82%b7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8bff33bd0d3df09612d55ecb2e82fbe4</guid>
				<title>MedicsKey.A started the discussion Digoxin過量或中毒時，因其高組織分布和強蛋白結合性，血液透析解毒效果差。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/digoxin%e9%81%8e%e9%87%8f%e6%88%96%e4%b8%ad%e6%af%92%e6%99%82%ef%bc%8c%e5%9b%a0%e5%85%b6%e9%ab%98%e7%b5%84%e7%b9%94%e5%88%86%e5%b8%83%e5%92%8c%e5%bc%b7%e8%9b%8b%e7%99%bd%e7%b5%90%e5%90%88%e6%80%a7/</link>
				<pubDate>Fri, 10 Jan 2025 16:20:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/digoxin%e9%81%8e%e9%87%8f%e6%88%96%e4%b8%ad%e6%af%92%e6%99%82%ef%bc%8c%e5%9b%a0%e5%85%b6%e9%ab%98%e7%b5%84%e7%b9%94%e5%88%86%e5%b8%83%e5%92%8c%e5%bc%b7%e8%9b%8b%e7%99%bd%e7%b5%90%e5%90%88%e6%80%a7/">Digoxin過量或中毒時，因其高組織分布和強蛋白結合性，血液透析解毒效果差。</a></p> <div class="bb-content-inr-wrap"><p>11212-75 藥理<br />
75.下列何種藥物使用過量或中毒，採用血液透析解毒效果最差？<br />
A.digoxin<br />
B.lithium<br />
C.theophylline<br />
D.carbamazepine</p>
<p>正確答案: A. digoxin</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-801"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/digoxin%e9%81%8e%e9%87%8f%e6%88%96%e4%b8%ad%e6%af%92%e6%99%82%ef%bc%8c%e5%9b%a0%e5%85%b6%e9%ab%98%e7%b5%84%e7%b9%94%e5%88%86%e5%b8%83%e5%92%8c%e5%bc%b7%e8%9b%8b%e7%99%bd%e7%b5%90%e5%90%88%e6%80%a7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d3ca63251fdc832a4ffb2de7f8a4cf84</guid>
				<title>MedicsKey.A started the discussion Propofol 不具有鎮痛效果。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/propofol-%e4%b8%8d%e5%85%b7%e6%9c%89%e9%8e%ae%e7%97%9b%e6%95%88%e6%9e%9c%e3%80%82/</link>
				<pubDate>Fri, 10 Jan 2025 16:16:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/propofol-%e4%b8%8d%e5%85%b7%e6%9c%89%e9%8e%ae%e7%97%9b%e6%95%88%e6%9e%9c%e3%80%82/">Propofol 不具有鎮痛效果。</a></p> <div class="bb-content-inr-wrap"><p>11212-74 藥理<br />
74.關於麻醉藥propofol作用的敘述，下列何者錯誤？<br />
A.具有鎮痛效果<br />
B.降低血壓，在老年人更明顯<br />
C.起效快，可用於誘導麻醉<br />
D.具有止吐作用</p>
<p>正確答案: A.具有鎮痛效果</p>
<p>為何正確: Propofol是一種靜脈注射用的全身麻醉劑，主要用於麻醉的誘導和維持，但其本身並不具有鎮痛作用。因此，選項A的敘述是錯誤的。Propofol會降低血壓，這個效果在老年人中更為顯著，起效速度快，常用於誘導麻醉，並且具有止吐作用。</p>
<p>選項: A<br />
詳解: Propofol&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-800"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/propofol-%e4%b8%8d%e5%85%b7%e6%9c%89%e9%8e%ae%e7%97%9b%e6%95%88%e6%9e%9c%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1483588d9549f344b3783a92ce7d389a</guid>
				<title>MedicsKey.A started the discussion Topiramate是一種治療癲癇發作的藥物，長期使用可導致體重降低，並與phentermine結合作為肥胖治療的複方藥物。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/topiramate%e6%98%af%e4%b8%80%e7%a8%ae%e6%b2%bb%e7%99%82%e7%99%b2%e7%99%87%e7%99%bc%e4%bd%9c%e7%9a%84%e8%97%a5%e7%89%a9%ef%bc%8c%e9%95%b7%e6%9c%9f%e4%bd%bf%e7%94%a8%e5%8f%af%e5%b0%8e%e8%87%b4%e9%ab%94/</link>
				<pubDate>Fri, 10 Jan 2025 16:04:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/topiramate%e6%98%af%e4%b8%80%e7%a8%ae%e6%b2%bb%e7%99%82%e7%99%b2%e7%99%87%e7%99%bc%e4%bd%9c%e7%9a%84%e8%97%a5%e7%89%a9%ef%bc%8c%e9%95%b7%e6%9c%9f%e4%bd%bf%e7%94%a8%e5%8f%af%e5%b0%8e%e8%87%b4%e9%ab%94/">Topiramate是一種治療癲癇發作的藥物，長期使用可導致體重降低，並與phentermine結合作為肥胖治療的複方藥物。</a></p> <div class="bb-content-inr-wrap"><p>11212-73 藥理<br />
73.下列那一個治療癲癇發作的藥物，多數患者長期使用造成顯著的體重降低，目前與phentermine作成複方用於肥胖治療？<br />
A.topiramate<br />
B.valproic&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-799"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/topiramate%e6%98%af%e4%b8%80%e7%a8%ae%e6%b2%bb%e7%99%82%e7%99%b2%e7%99%87%e7%99%bc%e4%bd%9c%e7%9a%84%e8%97%a5%e7%89%a9%ef%bc%8c%e9%95%b7%e6%9c%9f%e4%bd%bf%e7%94%a8%e5%8f%af%e5%b0%8e%e8%87%b4%e9%ab%94/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d6bd10679155eb87f9a3e1590b0813ac</guid>
				<title>MedicsKey.A started the discussion Selegiline的藥理作用機制是抑制單胺氧化酶B（monoamine oxidase B）。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/selegiline%e7%9a%84%e8%97%a5%e7%90%86%e4%bd%9c%e7%94%a8%e6%a9%9f%e5%88%b6%e6%98%af%e6%8a%91%e5%88%b6%e5%96%ae%e8%83%ba%e6%b0%a7%e5%8c%96%e9%85%b6b%ef%bc%88monoamine-oxidase-b%ef%bc%89%e3%80%82/</link>
				<pubDate>Fri, 10 Jan 2025 15:59:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/selegiline%e7%9a%84%e8%97%a5%e7%90%86%e4%bd%9c%e7%94%a8%e6%a9%9f%e5%88%b6%e6%98%af%e6%8a%91%e5%88%b6%e5%96%ae%e8%83%ba%e6%b0%a7%e5%8c%96%e9%85%b6b%ef%bc%88monoamine-oxidase-b%ef%bc%89%e3%80%82/">Selegiline的藥理作用機制是抑制單胺氧化酶B（monoamine oxidase B）。</a></p> <div class="bb-content-inr-wrap"><p>11212-72 藥理<br />
72.以levodopa治療帕金森氏症時，可併用selegiline增強levodopa的療效，下列何者為selegiline的藥理作用機制？<br />
A.抑制單胺氧化酶B（monoamine oxidase B）<br />
B.抑制兒茶酚-O-甲基轉移酶（catechol-O-methyltransferase）<br />
C.抑制多巴脫羧基酶（dopa decarboxylase）<br />
D.促進腦部神經末梢釋放多巴胺（dopamine）</p>
<p>正確答案: A.抑制單胺氧化酶B（monoamine oxidase B）</p>
<p>為何正確: Selegiline是一種選擇性單胺氧化酶B（monoamine&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-798"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/selegiline%e7%9a%84%e8%97%a5%e7%90%86%e4%bd%9c%e7%94%a8%e6%a9%9f%e5%88%b6%e6%98%af%e6%8a%91%e5%88%b6%e5%96%ae%e8%83%ba%e6%b0%a7%e5%8c%96%e9%85%b6b%ef%bc%88monoamine-oxidase-b%ef%bc%89%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2ba676202425f946ecac67c62d613b4d</guid>
				<title>MedicsKey.A started the discussion Zafirlukast是透過抑制支氣管平滑肌上白三烯(Leukotriene)受體的藥物。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/zafirlukast%e6%98%af%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e6%94%af%e6%b0%a3%e7%ae%a1%e5%b9%b3%e6%bb%91%e8%82%8c%e4%b8%8a%e7%99%bd%e4%b8%89%e7%83%afleukotriene%e5%8f%97%e9%ab%94%e7%9a%84%e8%97%a5/</link>
				<pubDate>Fri, 10 Jan 2025 15:32:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/zafirlukast%e6%98%af%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e6%94%af%e6%b0%a3%e7%ae%a1%e5%b9%b3%e6%bb%91%e8%82%8c%e4%b8%8a%e7%99%bd%e4%b8%89%e7%83%afleukotriene%e5%8f%97%e9%ab%94%e7%9a%84%e8%97%a5/">Zafirlukast是透過抑制支氣管平滑肌上白三烯(Leukotriene)受體的藥物。</a></p> <div class="bb-content-inr-wrap"><p>11212-71 藥理<br />
71.關於氣喘的藥物中，下列何者的作用機轉是透過抑制支氣管平滑肌上leukotriene受體的作用而來的？<br />
A.zafirlukast<br />
B.misoprostol<br />
C.zileuton<br />
D.iloprost</p>
<p>正確答案: A.zafirlukast<br />
為何正確: Zafirlukast是一種白三烯素受體拮抗劑(Leukotriene receptor antagonist)，其作用機轉是通過抑制支氣管平滑肌上的白三烯素(Leukotriene)受體，從而減少氣道的收縮和炎症反應，常用於氣喘的預防和慢性治療。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-797"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/zafirlukast%e6%98%af%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e6%94%af%e6%b0%a3%e7%ae%a1%e5%b9%b3%e6%bb%91%e8%82%8c%e4%b8%8a%e7%99%bd%e4%b8%89%e7%83%afleukotriene%e5%8f%97%e9%ab%94%e7%9a%84%e8%97%a5/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0edb37c6dbd52ce853e202e6b0720328</guid>
				<title>MedicsKey.A started the discussion Alprostadil 是用於治療男性勃起功能障礙（erectile dysfunction）的藥物。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/alprostadil-%e6%98%af%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%e7%94%b7%e6%80%a7%e5%8b%83%e8%b5%b7%e5%8a%9f%e8%83%bd%e9%9a%9c%e7%a4%99%ef%bc%88erectile-dysfunction%ef%bc%89%e7%9a%84%e8%97%a5%e7%89%a9/</link>
				<pubDate>Fri, 10 Jan 2025 15:21:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/alprostadil-%e6%98%af%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%e7%94%b7%e6%80%a7%e5%8b%83%e8%b5%b7%e5%8a%9f%e8%83%bd%e9%9a%9c%e7%a4%99%ef%bc%88erectile-dysfunction%ef%bc%89%e7%9a%84%e8%97%a5%e7%89%a9/">Alprostadil 是用於治療男性勃起功能障礙（erectile dysfunction）的藥物。</a></p> <div class="bb-content-inr-wrap"><p>11212-70 藥理<br />
70.下列何種藥物最適合用來治療男性勃起障礙（erectile dysfunction）？<br />
A.epoprostenol<br />
B.treprostinil<br />
C.misoprostol<br />
D.alprostadil</p>
<p>正確答案: D.alprostadil<br />
為何正確: Alprostadil 是一種前列腺素E1 (Prostaglandin E1, PGE1)，常用於治療男性勃起障礙（erectile dysfunction）。它能夠透過注射或陰莖插入式給藥來改善陰莖血流，從而達到並維持勃起。</p>
<p>選項: A<br />
詳解: Epoprostenol&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-796"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/alprostadil-%e6%98%af%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%e7%94%b7%e6%80%a7%e5%8b%83%e8%b5%b7%e5%8a%9f%e8%83%bd%e9%9a%9c%e7%a4%99%ef%bc%88erectile-dysfunction%ef%bc%89%e7%9a%84%e8%97%a5%e7%89%a9/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">daa2fe97e67b541ed9924d6af1aa0cd7</guid>
				<title>MedicsKey.A started the discussion 在吸入型皮質類固醇無法有效控制氣喘時，可考慮與長效β2-腎上腺素能受體激動劑(LABA)如formoterol併用以加強控制和預防氣喘發作。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%a8%e5%90%b8%e5%85%a5%e5%9e%8b%e7%9a%ae%e8%b3%aa%e9%a1%9e%e5%9b%ba%e9%86%87%e7%84%a1%e6%b3%95%e6%9c%89%e6%95%88%e6%8e%a7%e5%88%b6%e6%b0%a3%e5%96%98%e6%99%82%ef%bc%8c%e5%8f%af%e8%80%83%e6%85%ae/</link>
				<pubDate>Fri, 10 Jan 2025 15:13:37 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%a8%e5%90%b8%e5%85%a5%e5%9e%8b%e7%9a%ae%e8%b3%aa%e9%a1%9e%e5%9b%ba%e9%86%87%e7%84%a1%e6%b3%95%e6%9c%89%e6%95%88%e6%8e%a7%e5%88%b6%e6%b0%a3%e5%96%98%e6%99%82%ef%bc%8c%e5%8f%af%e8%80%83%e6%85%ae/">在吸入型皮質類固醇無法有效控制氣喘時，可考慮與長效β2-腎上腺素能受體激動劑(LABA)如formoterol併用以加強控制和預防氣喘發作。</a></p> <div class="bb-content-inr-wrap"><p>11212-68&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-795"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e5%9c%a8%e5%90%b8%e5%85%a5%e5%9e%8b%e7%9a%ae%e8%b3%aa%e9%a1%9e%e5%9b%ba%e9%86%87%e7%84%a1%e6%b3%95%e6%9c%89%e6%95%88%e6%8e%a7%e5%88%b6%e6%b0%a3%e5%96%98%e6%99%82%ef%bc%8c%e5%8f%af%e8%80%83%e6%85%ae/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5b46513bd93e3bed7db2ab318d4b7846</guid>
				<title>MedicsKey.A started the discussion Metoclopramide 的主要副作用是錐體外症狀（extrapyramidal symptom）。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/metoclopramide-%e7%9a%84%e4%b8%bb%e8%a6%81%e5%89%af%e4%bd%9c%e7%94%a8%e6%98%af%e9%8c%90%e9%ab%94%e5%a4%96%e7%97%87%e7%8b%80%ef%bc%88extrapyramidal-symptom%ef%bc%89%e3%80%82/</link>
				<pubDate>Fri, 10 Jan 2025 15:09:32 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/metoclopramide-%e7%9a%84%e4%b8%bb%e8%a6%81%e5%89%af%e4%bd%9c%e7%94%a8%e6%98%af%e9%8c%90%e9%ab%94%e5%a4%96%e7%97%87%e7%8b%80%ef%bc%88extrapyramidal-symptom%ef%bc%89%e3%80%82/">Metoclopramide 的主要副作用是錐體外症狀（extrapyramidal symptom）。</a></p> <div class="bb-content-inr-wrap"><p>11212-67 藥理<br />
67.下列何者是metoclopramide的主要副作用？<br />
A.胃食道逆流（gastroesophageal reflux）<br />
B.錐體外症狀（extrapyramidal symptom）<br />
C.嗜睡<br />
D.嘔吐</p>
<p>正確答案: B.錐體外症狀（extrapyramidal symptom）</p>
<p>為何正確: Metoclopramide是一種常用於治療噁心和胃食道逆流的藥物，其主要作用是促進胃排空和增強胃腸蠕動。然而，其主要副作用包括錐體外症狀（extrapyramidal&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-794"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/metoclopramide-%e7%9a%84%e4%b8%bb%e8%a6%81%e5%89%af%e4%bd%9c%e7%94%a8%e6%98%af%e9%8c%90%e9%ab%94%e5%a4%96%e7%97%87%e7%8b%80%ef%bc%88extrapyramidal-symptom%ef%bc%89%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d00ad722c5909482c2ce675018ca36cf</guid>
				<title>MedicsKey.A started the discussion 肉毒桿菌毒素（botulinum toxin）透過抑制突觸囊泡（synaptic vesicle）釋放乙醯膽鹼，進而達到消除皺紋的效果。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%89%e6%af%92%e6%a1%bf%e8%8f%8c%e6%af%92%e7%b4%a0%ef%bc%88botulinum-toxin%ef%bc%89%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e7%aa%81%e8%a7%b8%e5%9b%8a%e6%b3%a1%ef%bc%88synaptic-vesicle%ef%bc%89/</link>
				<pubDate>Fri, 10 Jan 2025 15:03:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%89%e6%af%92%e6%a1%bf%e8%8f%8c%e6%af%92%e7%b4%a0%ef%bc%88botulinum-toxin%ef%bc%89%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e7%aa%81%e8%a7%b8%e5%9b%8a%e6%b3%a1%ef%bc%88synaptic-vesicle%ef%bc%89/">肉毒桿菌毒素（botulinum toxin）透過抑制突觸囊泡（synaptic vesicle）釋放乙醯膽鹼，進而達到消除皺紋的效果。</a></p> <div class="bb-content-inr-wrap"><p>11212-66 藥理<br />
66.肉毒桿菌毒素（botulinum toxin）可局部注射於皮下，用以消除皺紋，其作用是透過下列何種機制而產生？<br />
A.抑制運動神經細胞的鈉離子通道（sodium channel）<br />
B.抑制骨骼肌細胞的鈉離子通道<br />
C.阻斷骨骼肌細胞的菸鹼性受體（nicotinic receptor）<br />
D.抑制突觸囊泡（synaptic vesicle）釋放乙醯膽鹼</p>
<p>正確答案: D.抑制突觸囊泡（synaptic vesicle）釋放乙醯膽鹼</p>
<p>為何正確: 肉毒桿菌毒素（botulinum&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-793"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e8%82%89%e6%af%92%e6%a1%bf%e8%8f%8c%e6%af%92%e7%b4%a0%ef%bc%88botulinum-toxin%ef%bc%89%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e7%aa%81%e8%a7%b8%e5%9b%8a%e6%b3%a1%ef%bc%88synaptic-vesicle%ef%bc%89/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0bd4712adfd53c96b2cf79dcc67ed97b</guid>
				<title>MedicsKey.A started the discussion Atropine是一種抗膽鹼藥物，無法降低眼壓且不適合用於治療隅角開放性青光眼（open-angle glaucoma）。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/atropine%e6%98%af%e4%b8%80%e7%a8%ae%e6%8a%97%e8%86%bd%e9%b9%bc%e8%97%a5%e7%89%a9%ef%bc%8c%e7%84%a1%e6%b3%95%e9%99%8d%e4%bd%8e%e7%9c%bc%e5%a3%93%e4%b8%94%e4%b8%8d%e9%81%a9%e5%90%88%e7%94%a8%e6%96%bc/</link>
				<pubDate>Fri, 10 Jan 2025 14:47:21 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/atropine%e6%98%af%e4%b8%80%e7%a8%ae%e6%8a%97%e8%86%bd%e9%b9%bc%e8%97%a5%e7%89%a9%ef%bc%8c%e7%84%a1%e6%b3%95%e9%99%8d%e4%bd%8e%e7%9c%bc%e5%a3%93%e4%b8%94%e4%b8%8d%e9%81%a9%e5%90%88%e7%94%a8%e6%96%bc/">Atropine是一種抗膽鹼藥物，無法降低眼壓且不適合用於治療隅角開放性青光眼（open-angle glaucoma）。</a></p> <div class="bb-content-inr-wrap"><p>11212-65 藥理<br />
65.下列局部點眼藥中，何者無法降低眼壓，對隅角開放性青光眼（open-angle glaucoma）也沒有改善效果？<br />
A.latanoprost<br />
B.apraclonidine<br />
C.timolol<br />
D.atropine</p>
<p>正確答案: D.atropine</p>
<p>為何正確: Atropine 是一種抗蕈毒鹼（muscarinic antagonist），主要作用在減緩瞳孔和睫狀肌的活動。由於它會導致瞳孔擴大和睫狀肌麻痺，這會增加眼內壓，因此不適用於治療隅角開放性青光眼（open-angle glaucoma），反而可能惡化病情。其他選項如&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-792"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/atropine%e6%98%af%e4%b8%80%e7%a8%ae%e6%8a%97%e8%86%bd%e9%b9%bc%e8%97%a5%e7%89%a9%ef%bc%8c%e7%84%a1%e6%b3%95%e9%99%8d%e4%bd%8e%e7%9c%bc%e5%a3%93%e4%b8%94%e4%b8%8d%e9%81%a9%e5%90%88%e7%94%a8%e6%96%bc/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">379f142dfde8305d706d25a48e8a277f</guid>
				<title>MedicsKey.A started the discussion Sacubitril的主要作用是抑制neprilysin（一種分解腎素的酶），從而間接增加brain natriuretic peptide（腦鈉尿肽）的濃度，並不直接活化brain natriuretic peptide受體。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/sacubitril%e7%9a%84%e4%b8%bb%e8%a6%81%e4%bd%9c%e7%94%a8%e6%98%af%e6%8a%91%e5%88%b6neprilysin%ef%bc%88%e4%b8%80%e7%a8%ae%e5%88%86%e8%a7%a3%e8%85%8e%e7%b4%a0%e7%9a%84%e9%85%b6%ef%bc%89%ef%bc%8c%e5%be%9e/</link>
				<pubDate>Fri, 10 Jan 2025 14:33:43 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/sacubitril%e7%9a%84%e4%b8%bb%e8%a6%81%e4%bd%9c%e7%94%a8%e6%98%af%e6%8a%91%e5%88%b6neprilysin%ef%bc%88%e4%b8%80%e7%a8%ae%e5%88%86%e8%a7%a3%e8%85%8e%e7%b4%a0%e7%9a%84%e9%85%b6%ef%bc%89%ef%bc%8c%e5%be%9e/">Sacubitril的主要作用是抑制neprilysin（一種分解腎素的酶），從而間接增加brain natriuretic peptide（腦鈉尿肽）的濃度，並不直接活化brain natriuretic peptide受體。</a></p> <div class="bb-content-inr-wrap"><p>11212-64 藥理<br />
64.下列關於sacubitril的敘述，何者錯誤？<br />
A.可活化brain natriuretic peptide受體<br />
B.可和valsartan合併使用<br />
C.可引起血管擴張<br />
D.用於治療慢性心臟衰竭</p>
<p>正確答案: A.可活化brain natriuretic peptide受體</p>
<p>為何正確: Sacubitril 是一種 neprilysin 抑制劑，neprilysin 是一種分解 natriuretic peptides（包含 brain natriuretic peptide, BNP）的酵素。因此，sacubitril 透過抑制 neprilysin，增加 natriuretic peptides&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-791"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/sacubitril%e7%9a%84%e4%b8%bb%e8%a6%81%e4%bd%9c%e7%94%a8%e6%98%af%e6%8a%91%e5%88%b6neprilysin%ef%bc%88%e4%b8%80%e7%a8%ae%e5%88%86%e8%a7%a3%e8%85%8e%e7%b4%a0%e7%9a%84%e9%85%b6%ef%bc%89%ef%bc%8c%e5%be%9e/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1ca781e2b1d5b1e491a83b494071322b</guid>
				<title>MedicsKey.A started the discussion Diazoxide是一種具有ATP-sensitive K-channel活化作用的降血壓藥，會使動脈血管擴張並抑制insulin(胰島素)釋放。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/diazoxide%e6%98%af%e4%b8%80%e7%a8%ae%e5%85%b7%e6%9c%89atp-sensitive-k-channel%e6%b4%bb%e5%8c%96%e4%bd%9c%e7%94%a8%e7%9a%84%e9%99%8d%e8%a1%80%e5%a3%93%e8%97%a5%ef%bc%8c%e6%9c%83%e4%bd%bf%e5%8b%95/</link>
				<pubDate>Fri, 10 Jan 2025 14:24:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/diazoxide%e6%98%af%e4%b8%80%e7%a8%ae%e5%85%b7%e6%9c%89atp-sensitive-k-channel%e6%b4%bb%e5%8c%96%e4%bd%9c%e7%94%a8%e7%9a%84%e9%99%8d%e8%a1%80%e5%a3%93%e8%97%a5%ef%bc%8c%e6%9c%83%e4%bd%bf%e5%8b%95/">Diazoxide是一種具有ATP-sensitive K-channel活化作用的降血壓藥，會使動脈血管擴張並抑制insulin(胰島素)釋放。</a></p> <div class="bb-content-inr-wrap"><p>11212-63 藥理<br />
63.下列降血壓藥何者具有ATP-sensitive K-channel活化作用，會使動脈血管擴張，但會抑制insulin釋放？<br />
A.fenoldopam<br />
B.captopril<br />
C.diazoxide<br />
D.minoxidil</p>
<p>正確答案: C. diazoxide</p>
<p>為何正確: Diazoxide 是一種具有 ATP-sensitive K-channel 活化作用的降血壓藥物。它能夠使動脈血管擴張，並且它會抑制胰島素的釋放，這一點在糖尿病患者中尤其重要，因為 diazoxide 可能導致血糖升高。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-790"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/diazoxide%e6%98%af%e4%b8%80%e7%a8%ae%e5%85%b7%e6%9c%89atp-sensitive-k-channel%e6%b4%bb%e5%8c%96%e4%bd%9c%e7%94%a8%e7%9a%84%e9%99%8d%e8%a1%80%e5%a3%93%e8%97%a5%ef%bc%8c%e6%9c%83%e4%bd%bf%e5%8b%95/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">af0ac401f4eeafc54c719503b383f4fc</guid>
				<title>MedicsKey.A started the discussion Methyldopa在中樞轉換成α-methylnorepinephrine，適用於腎功能不全的高血壓患者。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/methyldopa%e5%9c%a8%e4%b8%ad%e6%a8%9e%e8%bd%89%e6%8f%9b%e6%88%90%ce%b1-methylnorepinephrine%ef%bc%8c%e9%81%a9%e7%94%a8%e6%96%bc%e8%85%8e%e5%8a%9f%e8%83%bd%e4%b8%8d%e5%85%a8%e7%9a%84%e9%ab%98%e8%a1%80/</link>
				<pubDate>Fri, 10 Jan 2025 14:13:23 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/methyldopa%e5%9c%a8%e4%b8%ad%e6%a8%9e%e8%bd%89%e6%8f%9b%e6%88%90%ce%b1-methylnorepinephrine%ef%bc%8c%e9%81%a9%e7%94%a8%e6%96%bc%e8%85%8e%e5%8a%9f%e8%83%bd%e4%b8%8d%e5%85%a8%e7%9a%84%e9%ab%98%e8%a1%80/">Methyldopa在中樞轉換成α-methylnorepinephrine，適用於腎功能不全的高血壓患者。</a></p> <div class="bb-content-inr-wrap"><p>11212-62&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-789"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/methyldopa%e5%9c%a8%e4%b8%ad%e6%a8%9e%e8%bd%89%e6%8f%9b%e6%88%90%ce%b1-methylnorepinephrine%ef%bc%8c%e9%81%a9%e7%94%a8%e6%96%bc%e8%85%8e%e5%8a%9f%e8%83%bd%e4%b8%8d%e5%85%a8%e7%9a%84%e9%ab%98%e8%a1%80/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">98dde5acb385d2b332b308827252d8e0</guid>
				<title>MedicsKey.A started the discussion Aminoglutethimide 透過抑制膽固醇（cholesterol）轉換成孕烯醇酮（pregnenolone）來阻斷皮質醇和皮質酮的生合成。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/aminoglutethimide-%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e8%86%bd%e5%9b%ba%e9%86%87%ef%bc%88cholesterol%ef%bc%89%e8%bd%89%e6%8f%9b%e6%88%90%e5%ad%95%e7%83%af%e9%86%87%e9%85%ae%ef%bc%88pregnenolone/</link>
				<pubDate>Fri, 10 Jan 2025 14:03:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/aminoglutethimide-%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e8%86%bd%e5%9b%ba%e9%86%87%ef%bc%88cholesterol%ef%bc%89%e8%bd%89%e6%8f%9b%e6%88%90%e5%ad%95%e7%83%af%e9%86%87%e9%85%ae%ef%bc%88pregnenolone/">Aminoglutethimide 透過抑制膽固醇（cholesterol）轉換成孕烯醇酮（pregnenolone）來阻斷皮質醇和皮質酮的生合成。</a></p> <div class="bb-content-inr-wrap"><p>11212-61 藥理<br />
61.下列何種腎上腺皮質素拮抗劑的作用，係透過抑制膽固醇（cholesterol）轉換成孕烯醇酮（pregnenolone）的作用，來阻斷皮質醇和皮質酮的生合成？<br />
A.aminoglutethimide<br />
B.metyrapone<br />
C.mifepristone<br />
D.trilostane</p>
<p>正確答案:<br />
A. aminoglutethimide</p>
<p>為何正確:<br />
Aminoglutethimide 是一種腎上腺皮質素拮抗劑，其作用機制是透過抑制膽固醇轉換成孕烯醇酮（pregnenolone），從而阻斷皮質醇（cortisol）和皮質酮（corticosterone）的生合成。這個過程是一個關鍵的早期步驟，影響到整個類固醇激素的生產路徑。</p>
<p>選項:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-788"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/aminoglutethimide-%e9%80%8f%e9%81%8e%e6%8a%91%e5%88%b6%e8%86%bd%e5%9b%ba%e9%86%87%ef%bc%88cholesterol%ef%bc%89%e8%bd%89%e6%8f%9b%e6%88%90%e5%ad%95%e7%83%af%e9%86%87%e9%85%ae%ef%bc%88pregnenolone/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8da66f826a053eb0e458d0da1017d0f8</guid>
				<title>MedicsKey.A started the discussion Raloxifene是作用於雌激素受體的藥物，用於治療停經後婦女的骨質疏鬆。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/raloxifene%e6%98%af%e4%bd%9c%e7%94%a8%e6%96%bc%e9%9b%8c%e6%bf%80%e7%b4%a0%e5%8f%97%e9%ab%94%e7%9a%84%e8%97%a5%e7%89%a9%ef%bc%8c%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%e5%81%9c%e7%b6%93%e5%be%8c%e5%a9%a6/</link>
				<pubDate>Fri, 10 Jan 2025 13:44:20 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/raloxifene%e6%98%af%e4%bd%9c%e7%94%a8%e6%96%bc%e9%9b%8c%e6%bf%80%e7%b4%a0%e5%8f%97%e9%ab%94%e7%9a%84%e8%97%a5%e7%89%a9%ef%bc%8c%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%e5%81%9c%e7%b6%93%e5%be%8c%e5%a9%a6/">Raloxifene是作用於雌激素受體的藥物，用於治療停經後婦女的骨質疏鬆。</a></p> <div class="bb-content-inr-wrap"><p>11212-60 藥理<br />
60.下列何種藥物主要作用對象為雌激素受體，可治療停經後婦女的骨質疏鬆？<br />
A.omeprazole<br />
B.denosumab<br />
C.raloxifene<br />
D.prednisolone</p>
<p>正確答案:<br />
C.raloxifene</p>
<p>為何正確:<br />
Raloxifene 是一種選擇性雌激素受體調節劑（Selective Estrogen Receptor Modulator, SERM），其主要作用對象為雌激素受體。它模擬雌激素在骨骼上的作用，因此能夠有效地用於治療停經後婦女的骨質疏鬆。它可以增加骨密度並降低骨折的風險。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-787"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/raloxifene%e6%98%af%e4%bd%9c%e7%94%a8%e6%96%bc%e9%9b%8c%e6%bf%80%e7%b4%a0%e5%8f%97%e9%ab%94%e7%9a%84%e8%97%a5%e7%89%a9%ef%bc%8c%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%e5%81%9c%e7%b6%93%e5%be%8c%e5%a9%a6/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">f434370f5dd8a92881630fb1ea8fd5ca</guid>
				<title>MedicsKey.A started the discussion 生長激素（somatotropin）主要作用在酪胺酸激酶受體（tyrosine kinase receptor）而非G蛋白耦合受體（GPCR）。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e7%94%9f%e9%95%b7%e6%bf%80%e7%b4%a0%ef%bc%88somatotropin%ef%bc%89%e4%b8%bb%e8%a6%81%e4%bd%9c%e7%94%a8%e5%9c%a8%e9%85%aa%e8%83%ba%e9%85%b8%e6%bf%80%e9%85%b6%e5%8f%97%e9%ab%94%ef%bc%88tyrosine-kinase-r/</link>
				<pubDate>Fri, 10 Jan 2025 13:31:28 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e7%94%9f%e9%95%b7%e6%bf%80%e7%b4%a0%ef%bc%88somatotropin%ef%bc%89%e4%b8%bb%e8%a6%81%e4%bd%9c%e7%94%a8%e5%9c%a8%e9%85%aa%e8%83%ba%e9%85%b8%e6%bf%80%e9%85%b6%e5%8f%97%e9%ab%94%ef%bc%88tyrosine-kinase-r/">生長激素（somatotropin）主要作用在酪胺酸激酶受體（tyrosine kinase receptor）而非G蛋白耦合受體（GPCR）。</a></p> <div class="bb-content-inr-wrap"><p>11212-59 藥理<br />
59.下列何種藥物的主要作用對象，不是G蛋白耦合受體（G protein-couple receptor, GPCR）？<br />
A.somatotropin<br />
B.bromocriptine<br />
C.desmopressin<br />
D.leuprolide</p>
<p>正確答案: A.somatotropin</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-786"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e7%94%9f%e9%95%b7%e6%bf%80%e7%b4%a0%ef%bc%88somatotropin%ef%bc%89%e4%b8%bb%e8%a6%81%e4%bd%9c%e7%94%a8%e5%9c%a8%e9%85%aa%e8%83%ba%e9%85%b8%e6%bf%80%e9%85%b6%e5%8f%97%e9%ab%94%ef%bc%88tyrosine-kinase-r/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7b80dcd43a09ac326db300f5f75ec17e</guid>
				<title>MedicsKey.A started the discussion Simvastatin主要是通過抑制HMG-CoA reductase（3-hydroxy-3-methyl-glutaryl-coenzyme A還原酶）來降低膽固醇合成以減少血中LDL含量。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/simvastatin%e4%b8%bb%e8%a6%81%e6%98%af%e9%80%9a%e9%81%8e%e6%8a%91%e5%88%b6hmg-coa-reductase%ef%bc%883-hydroxy-3-methyl-glutaryl-coenzyme-a%e9%82%84%e5%8e%9f%e9%85%b6%ef%bc%89%e4%be%86%e9%99%8d/</link>
				<pubDate>Fri, 10 Jan 2025 12:48:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/simvastatin%e4%b8%bb%e8%a6%81%e6%98%af%e9%80%9a%e9%81%8e%e6%8a%91%e5%88%b6hmg-coa-reductase%ef%bc%883-hydroxy-3-methyl-glutaryl-coenzyme-a%e9%82%84%e5%8e%9f%e9%85%b6%ef%bc%89%e4%be%86%e9%99%8d/">Simvastatin主要是通過抑制HMG-CoA reductase（3-hydroxy-3-methyl-glutaryl-coenzyme A還原酶）來降低膽固醇合成以減少血中LDL含量。</a></p> <div class="bb-content-inr-wrap"><p>11212-58 藥理<br />
58.Simvastatin主要療效在於降低血中LDL含量，同時具有緩解血管發炎及粥狀動脈形成的作用。此藥物主要之作用機制為何？<br />
A.活化PPAR-α受體<br />
B.抑制HMG-CoA reductase活性<br />
C.抑制腸道運輸蛋白NPC1L1<br />
D.與膽酸（bile acid）結合</p>
<p>正確答案:<br />
B.抑制HMG-CoA reductase活性</p>
<p>為何正確:<br />
Simvastatin屬於statin類藥物，其主要作用機制是抑制HMG-CoA&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-785"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/simvastatin%e4%b8%bb%e8%a6%81%e6%98%af%e9%80%9a%e9%81%8e%e6%8a%91%e5%88%b6hmg-coa-reductase%ef%bc%883-hydroxy-3-methyl-glutaryl-coenzyme-a%e9%82%84%e5%8e%9f%e9%85%b6%ef%bc%89%e4%be%86%e9%99%8d/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">9a2ded11d51b1c98e2d94143081bc1c2</guid>
				<title>MedicsKey.A started the discussion Misoprostol是一種合成的前列腺素E1（PGE1）類似物。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/misoprostol%e6%98%af%e4%b8%80%e7%a8%ae%e5%90%88%e6%88%90%e7%9a%84%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e1%ef%bc%88pge1%ef%bc%89%e9%a1%9e%e4%bc%bc%e7%89%a9%e3%80%82/</link>
				<pubDate>Fri, 10 Jan 2025 07:23:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/misoprostol%e6%98%af%e4%b8%80%e7%a8%ae%e5%90%88%e6%88%90%e7%9a%84%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e1%ef%bc%88pge1%ef%bc%89%e9%a1%9e%e4%bc%bc%e7%89%a9%e3%80%82/">Misoprostol是一種合成的前列腺素E1（PGE1）類似物。</a></p> <div class="bb-content-inr-wrap"><p>11212-57 藥理<br />
57.下列關於可刺激子宮肌肉收縮（oxytocic action）自泌素及其相關藥物之敘述，何者錯誤？<br />
A.PGE2及 PGF2α具強效收縮作用<br />
B.misoprostol具類似PGF2α之作用<br />
C.dinoprostone具類似PGE2之作用<br />
D.carboprost具類似PGF2α之作用</p>
<p>正確答案: B. misoprostol具類似PGF2α之作用</p>
<p>為何正確: Misoprostol是一種合成前列腺素E1（Prostaglandin E1,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-784"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/misoprostol%e6%98%af%e4%b8%80%e7%a8%ae%e5%90%88%e6%88%90%e7%9a%84%e5%89%8d%e5%88%97%e8%85%ba%e7%b4%a0e1%ef%bc%88pge1%ef%bc%89%e9%a1%9e%e4%bc%bc%e7%89%a9%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">17fb8622aa770a4ab63f593908d69b68</guid>
				<title>MedicsKey.A started the discussion 年長者使用Rivaroxaban時，應注意藥物的半衰期通常會延長。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e5%b9%b4%e9%95%b7%e8%80%85%e4%bd%bf%e7%94%a8rivaroxaban%e6%99%82%ef%bc%8c%e6%87%89%e6%b3%a8%e6%84%8f%e8%97%a5%e7%89%a9%e7%9a%84%e5%8d%8a%e8%a1%b0%e6%9c%9f%e9%80%9a%e5%b8%b8%e6%9c%83%e5%bb%b6%e9%95%b7/</link>
				<pubDate>Fri, 10 Jan 2025 07:01:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e5%b9%b4%e9%95%b7%e8%80%85%e4%bd%bf%e7%94%a8rivaroxaban%e6%99%82%ef%bc%8c%e6%87%89%e6%b3%a8%e6%84%8f%e8%97%a5%e7%89%a9%e7%9a%84%e5%8d%8a%e8%a1%b0%e6%9c%9f%e9%80%9a%e5%b8%b8%e6%9c%83%e5%bb%b6%e9%95%b7/">年長者使用Rivaroxaban時，應注意藥物的半衰期通常會延長。</a></p> <div class="bb-content-inr-wrap"><p>11212-56 藥理<br />
56.有關預防性抗血栓藥物（antithrombotic drug）rivaroxaban之相關敘述，下列何者錯誤？<br />
A.主要機制為抑制凝血因子Xa作用<br />
B.可用於治療靜脈血栓症<br />
C.年長者使用時，應注意此藥物之半衰期會縮短<br />
D.目前andexanet alfa為直接性解毒劑</p>
<p>正確答案:<br />
C.年長者使用時，應注意此藥物之半衰期會縮短</p>
<p>為何正確:<br />
Rivaroxaban為直接口服抗凝血劑，主要機制為抑制凝血因子Xa。它可用於治療和預防靜脈血栓症。對於年長者而言，應注意的是藥物的清除率可能減少，半衰期可能會延長，而非縮短。此外，andexanet&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-783"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e5%b9%b4%e9%95%b7%e8%80%85%e4%bd%bf%e7%94%a8rivaroxaban%e6%99%82%ef%bc%8c%e6%87%89%e6%b3%a8%e6%84%8f%e8%97%a5%e7%89%a9%e7%9a%84%e5%8d%8a%e8%a1%b0%e6%9c%9f%e9%80%9a%e5%b8%b8%e6%9c%83%e5%bb%b6%e9%95%b7/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">cea42cd80b6e07a44db3df9ab790ca32</guid>
				<title>MedicsKey.A started the discussion Dicloxacillin適合用於治療β-lactamase positive金黃色葡萄球菌（Staphylococcus aureus）感染。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/dicloxacillin%e9%81%a9%e5%90%88%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%ce%b2-lactamase-positive%e9%87%91%e9%bb%83%e8%89%b2%e8%91%a1%e8%90%84%e7%90%83%e8%8f%8c%ef%bc%88staphylococcus-aureus%ef%bc%89/</link>
				<pubDate>Fri, 10 Jan 2025 06:55:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/dicloxacillin%e9%81%a9%e5%90%88%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%ce%b2-lactamase-positive%e9%87%91%e9%bb%83%e8%89%b2%e8%91%a1%e8%90%84%e7%90%83%e8%8f%8c%ef%bc%88staphylococcus-aureus%ef%bc%89/">Dicloxacillin適合用於治療β-lactamase positive金黃色葡萄球菌（Staphylococcus aureus）感染。</a></p> <div class="bb-content-inr-wrap"><p>11212-55 藥理<br />
55.林先生因車禍受傷，傷口已化膿才就醫，經檢驗為β-lactamase positive金黃色葡萄球菌（Staphylococcus aureus）感染，下列何種抗生素最適合用於治療？<br />
A.ampicillin<br />
B.dicloxacillin<br />
C.penicillin G<br />
D.piperacillin</p>
<p>正確答案: B.dicloxacillin</p>
<p>為何正確: Dicloxacillin是一種抗耐藥金黃色葡萄球菌的青黴素類抗生素，能夠抵抗β-內醯胺酶(β-lactamase)的作用。金黃色葡萄球菌（Staphylococcus aureus）若為β-lactamase&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-782"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/dicloxacillin%e9%81%a9%e5%90%88%e7%94%a8%e6%96%bc%e6%b2%bb%e7%99%82%ce%b2-lactamase-positive%e9%87%91%e9%bb%83%e8%89%b2%e8%91%a1%e8%90%84%e7%90%83%e8%8f%8c%ef%bc%88staphylococcus-aureus%ef%bc%89/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0eef8613e59b654312199b38165db160</guid>
				<title>MedicsKey.A started the discussion Pembrolizumab專一性結合programmed death-1 receptor（PD-1）。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/pembrolizumab%e5%b0%88%e4%b8%80%e6%80%a7%e7%b5%90%e5%90%88programmed-death-1-receptor%ef%bc%88pd-1%ef%bc%89%e3%80%82/</link>
				<pubDate>Fri, 10 Jan 2025 06:40:18 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/pembrolizumab%e5%b0%88%e4%b8%80%e6%80%a7%e7%b5%90%e5%90%88programmed-death-1-receptor%ef%bc%88pd-1%ef%bc%89%e3%80%82/">Pembrolizumab專一性結合programmed death-1 receptor（PD-1）。</a></p> <div class="bb-content-inr-wrap"><p>11212-54 藥理<br />
54.Pembrolizumab為免疫檢查點抑制劑（immune checkpoint inhibitor），可用於治療癌症，下列何者為此單株抗體專一性結合的蛋白？<br />
A.epidermal growth factor receptor（EGFR）<br />
B.programmed death-1 receptor（PD-1）<br />
C.programmed death ligand 1（PD-L1）<br />
D.cytotoxic T-lymphocyte-associated antigen 4（CTLA-4）</p>
<p>正確答案: B. programmed death-1 receptor（PD-1）</p>
<p>為何正確:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-781"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/pembrolizumab%e5%b0%88%e4%b8%80%e6%80%a7%e7%b5%90%e5%90%88programmed-death-1-receptor%ef%bc%88pd-1%ef%bc%89%e3%80%82/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">9e8d45956fe346a4830349aff4669fb4</guid>
				<title>MedicsKey.A started the discussion Vincristine與神經毒性（neurotoxicity）相關，尤其是會引發周邊神經病變。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/vincristine%e8%88%87%e7%a5%9e%e7%b6%93%e6%af%92%e6%80%a7%ef%bc%88neurotoxicity%ef%bc%89%e7%9b%b8%e9%97%9c%ef%bc%8c%e5%b0%a4%e5%85%b6%e6%98%af%e6%9c%83%e5%bc%95%e7%99%bc%e5%91%a8%e9%82%8a%e7%a5%9e/</link>
				<pubDate>Fri, 10 Jan 2025 06:03:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/vincristine%e8%88%87%e7%a5%9e%e7%b6%93%e6%af%92%e6%80%a7%ef%bc%88neurotoxicity%ef%bc%89%e7%9b%b8%e9%97%9c%ef%bc%8c%e5%b0%a4%e5%85%b6%e6%98%af%e6%9c%83%e5%bc%95%e7%99%bc%e5%91%a8%e9%82%8a%e7%a5%9e/">Vincristine與神經毒性（neurotoxicity）相關，尤其是會引發周邊神經病變。</a></p> <div class="bb-content-inr-wrap"><p>11212-53 藥理<br />
53.下列抗癌藥物與其主要產生毒性之配對，何者錯誤？<br />
A.doxorubicin－心臟毒性<br />
B.oxaliplatin－周邊感覺神經病變<br />
C.vincristine－肺纖維化<br />
D.cyclophosphamide－出血性膀胱炎</p>
<p>正確答案: C.vincristine－肺纖維化</p>
<p>為何正確:<br />
Vincristine主要的毒性是神經毒性，特別是會引起周邊神經病變，而非肺纖維化。肺纖維化較常見於另一類藥物如bleomycin引起。</p>
<p>選項: A<br />
詳解: Doxorubicin&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-780"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/vincristine%e8%88%87%e7%a5%9e%e7%b6%93%e6%af%92%e6%80%a7%ef%bc%88neurotoxicity%ef%bc%89%e7%9b%b8%e9%97%9c%ef%bc%8c%e5%b0%a4%e5%85%b6%e6%98%af%e6%9c%83%e5%bc%95%e7%99%bc%e5%91%a8%e9%82%8a%e7%a5%9e/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6dbb691032d596a87971ca88db4107ae</guid>
				<title>MedicsKey.A started the discussion Rifampin抗藥性產生是因為細菌的RNA聚合酶（RNA polymerase）結構改變。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/rifampin%e6%8a%97%e8%97%a5%e6%80%a7%e7%94%a2%e7%94%9f%e6%98%af%e5%9b%a0%e7%82%ba%e7%b4%b0%e8%8f%8c%e7%9a%84rna%e8%81%9a%e5%90%88%e9%85%b6%ef%bc%88rna-polymerase%ef%bc%89%e7%b5%90%e6%a7%8b%e6%94%b9/</link>
				<pubDate>Fri, 10 Jan 2025 05:51:22 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/rifampin%e6%8a%97%e8%97%a5%e6%80%a7%e7%94%a2%e7%94%9f%e6%98%af%e5%9b%a0%e7%82%ba%e7%b4%b0%e8%8f%8c%e7%9a%84rna%e8%81%9a%e5%90%88%e9%85%b6%ef%bc%88rna-polymerase%ef%bc%89%e7%b5%90%e6%a7%8b%e6%94%b9/">Rifampin抗藥性產生是因為細菌的RNA聚合酶（RNA polymerase）結構改變。</a></p> <div class="bb-content-inr-wrap"><p>11212-52 藥理<br />
52.關於rifampin產生的作用，下列敘述何者錯誤？<br />
A.抗藥性產生可能是結合到DNA聚合酶的能力降低<br />
B.於開放性肺結核病，必須與isoniazid併用，以預防抗藥性的發生<br />
C.會加速methadone或anticoagulants排除，是因為能誘發細胞色素P450（cytochrome&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-779"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/rifampin%e6%8a%97%e8%97%a5%e6%80%a7%e7%94%a2%e7%94%9f%e6%98%af%e5%9b%a0%e7%82%ba%e7%b4%b0%e8%8f%8c%e7%9a%84rna%e8%81%9a%e5%90%88%e9%85%b6%ef%bc%88rna-polymerase%ef%bc%89%e7%b5%90%e6%a7%8b%e6%94%b9/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5e77413a708c2154c0be5e0eb8741b66</guid>
				<title>MedicsKey.A started the discussion 非競爭性拮抗劑（noncompetitive antagonist）無法被持續增高濃度的致效劑（agonist）逆轉其效能。 in the forum 藥理學</title>
				<link>https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e9%9d%9e%e7%ab%b6%e7%88%ad%e6%80%a7%e6%8b%ae%e6%8a%97%e5%8a%91%ef%bc%88noncompetitive-antagonist%ef%bc%89%e7%84%a1%e6%b3%95%e8%a2%ab%e6%8c%81%e7%ba%8c%e5%a2%9e%e9%ab%98%e6%bf%83%e5%ba%a6%e7%9a%84/</link>
				<pubDate>Fri, 10 Jan 2025 05:35:52 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e9%9d%9e%e7%ab%b6%e7%88%ad%e6%80%a7%e6%8b%ae%e6%8a%97%e5%8a%91%ef%bc%88noncompetitive-antagonist%ef%bc%89%e7%84%a1%e6%b3%95%e8%a2%ab%e6%8c%81%e7%ba%8c%e5%a2%9e%e9%ab%98%e6%bf%83%e5%ba%a6%e7%9a%84/">非競爭性拮抗劑（noncompetitive antagonist）無法被持續增高濃度的致效劑（agonist）逆轉其效能。</a></p> <div class="bb-content-inr-wrap"><p>11212-51 藥理<br />
51.下列何者在固定濃度下，無法被持續增高濃度的致效劑（agonist）逆轉其效能（efficacy）？<br />
A.競爭性拮抗劑（competitive antagonist）<br />
B.非競爭性拮抗劑（noncompetitive antagonist）<br />
C.反促效劑（inverse agonist）<br />
D.部分促效劑（partial agonist）</p>
<p>正確答案: B.非競爭性拮抗劑（noncompetitive antagonist）</p>
<p>為何正確: 非競爭性拮抗劑（noncompetitive&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-778"><a href="https://medicskey.com/groups/%e8%97%a5%e7%90%86%e5%ad%b8/forum/discussion/%e9%9d%9e%e7%ab%b6%e7%88%ad%e6%80%a7%e6%8b%ae%e6%8a%97%e5%8a%91%ef%bc%88noncompetitive-antagonist%ef%bc%89%e7%84%a1%e6%b3%95%e8%a2%ab%e6%8c%81%e7%ba%8c%e5%a2%9e%e9%ab%98%e6%bf%83%e5%ba%a6%e7%9a%84/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b7cd8578769a6683b6904f7ba0a15ad2</guid>
				<title>MedicsKey.A started the discussion 避免同儕間之肢體暴力與語言暴力與人因工程（ergonomics）無關。 in the forum 生物統計 &#38; 流行病學</title>
				<link>https://medicskey.com/groups/%e7%94%9f%e7%89%a9%e7%b5%b1%e8%a8%88-%e6%b5%81%e8%a1%8c%e7%97%85%e5%ad%b8/forum/discussion/%e9%81%bf%e5%85%8d%e5%90%8c%e5%84%95%e9%96%93%e4%b9%8b%e8%82%a2%e9%ab%94%e6%9a%b4%e5%8a%9b%e8%88%87%e8%aa%9e%e8%a8%80%e6%9a%b4%e5%8a%9b%e8%88%87%e4%ba%ba%e5%9b%a0%e5%b7%a5%e7%a8%8b%ef%bc%88ergonomics/</link>
				<pubDate>Fri, 10 Jan 2025 05:27:19 +0800</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://medicskey.com/groups/%e7%94%9f%e7%89%a9%e7%b5%b1%e8%a8%88-%e6%b5%81%e8%a1%8c%e7%97%85%e5%ad%b8/forum/discussion/%e9%81%bf%e5%85%8d%e5%90%8c%e5%84%95%e9%96%93%e4%b9%8b%e8%82%a2%e9%ab%94%e6%9a%b4%e5%8a%9b%e8%88%87%e8%aa%9e%e8%a8%80%e6%9a%b4%e5%8a%9b%e8%88%87%e4%ba%ba%e5%9b%a0%e5%b7%a5%e7%a8%8b%ef%bc%88ergonomics/">避免同儕間之肢體暴力與語言暴力與人因工程（ergonomics）無關。</a></p> <div class="bb-content-inr-wrap"><p>11212-42 公衛<br />
42.要預防人因性（ergonomics）危害，下列何者最無相關？<br />
A.良好物料搬運習慣<br />
B.正確姿勢<br />
C.避免重複性的工作內容<br />
D.避免同儕間之肢體暴力與語言暴力</p>
<p>正確答案: D.避免同儕間之肢體暴力與語言暴力</p>
<p>為何正確: 人因性危害（ergonomics）主要涉及的是人體在工作環境中的物理互動，如姿勢、物料搬運及重複性工作等。這些因素直接影響到人體的生理負荷及健康風險。而同儕間之肢體暴力與語言暴力屬於人際關係或心理層面的問題，與人因工效學（ergonomics）並無直接關聯。</p>
<p>選項: A<br />
詳解:&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-777"><a href="https://medicskey.com/groups/%e7%94%9f%e7%89%a9%e7%b5%b1%e8%a8%88-%e6%b5%81%e8%a1%8c%e7%97%85%e5%ad%b8/forum/discussion/%e9%81%bf%e5%85%8d%e5%90%8c%e5%84%95%e9%96%93%e4%b9%8b%e8%82%a2%e9%ab%94%e6%9a%b4%e5%8a%9b%e8%88%87%e8%aa%9e%e8%a8%80%e6%9a%b4%e5%8a%9b%e8%88%87%e4%ba%ba%e5%9b%a0%e5%b7%a5%e7%a8%8b%ef%bc%88ergonomics/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>
		